Genentech, Inc., et al. v. Sandoz, Inc., et al.

1:19-cv-00078 | Delaware District Court

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Division Wilmington
Judge Judge Richard G. Andrews
Filed Jan. 14, 2019
Terminated April 19, 2022
Case Flags CLOSED, LEAD, and PATENT
Nature of Suit 835 Patent - Abbreviated New Drug Application (ANDA)
Cause 35:271 Patent Infringement
Jury Demand None
Last Updated: 6 days, 17 hours ago Show Interactive Timeline
Upcoming Events
18 Months
  • 9/22/2026
Date of Expiration of Patent: multiple expiration dates from 9/22/2026 through 8/30/2033.Thirty Month Stay Deadline: 5/14/2022.
Date of Expiration of Patent: multiple expiration dates from 9/22/2026 through August 30, 2033.Thirty Month Stay Deadline: 6/9/2022.
Source
Add
Filing Date # Docket Text
2/3/2023Remark: The bench trial exhibits (see D.I. 362 Exhibit List) have been destroyed per the authority at D.I. 439 . (nms) (Entered: 02/03/2023)
2/3/2023Joint Letter to The Clerk of Court, regarding the discarding of trial exhibits (D.I. 438 ). (Clark, Cameron) Modified on 2/3/2023 (nms). (Entered: 02/03/2023)
1/30/2023 Letter to Counsel, from the Clerk of Court, regarding return of trial exhibits -(see D.I. 362 Exhibit List). (nms) (Entered: 01/30/2023)
1/30/2023MANDATE of USCA as to 397 Notice of Appeal (Federal Circuit), filed by Genentech, Inc., InterMune, Inc.. USCA Decision: Affirmed. (Attachments: # 1 Opinion, # 2 Judgment)(nms) (Entered: 01/30/2023)
10/6/2022436
  • Order
ORAL ORDER: The redactions at D.I. 389 , 390 , 391 , and 393 as supported by the declarations at D.I. 403 and D.I. 404 are APPROVED. Ordered by Judge Richard G. Andrews on 10/6/2022. (nms) (Entered: 10/06/2022)
6/16/2022MANDATE of USCA as to 433 Notice of Cross Appeal, filed by Lek Pharmaceuticals D.D., Sandoz Inc.. USCA Decision: The motion is granted. Appeal No. 2022-1714 is dismissed. The revised official caption for the remaining appeal, Appeal No. 2022-1595, is reflected above. (2) Each side shall bear its own costs in Appeal No. 2022-1714. (3) The Clerk of Court shall transmit a copy of this order to the merits panel assigned to Appeal No. 2022 1595. (4) Genentech, Inc. and InterMune, Inc.s reply brief in Appeal No. 2022-1595 is due no later than July 5, 2022. (nms) (Entered: 06/16/2022)
4/22/2022NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 433 Notice of Cross Appeal, filed by Lek Pharmaceuticals D.D., Sandoz Inc.. USCA Case Number 2022-1714. (nms) (Entered: 04/22/2022)
4/21/2022Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 433 Notice of Cross Appeal. (nmg) (Entered: 04/21/2022)
4/21/2022Notification regarding 433 Notice of Cross Appeal sent to Reporter Triozzi. (nmg) (Entered: 04/21/2022)
4/21/2022APPEAL - Credit Card Payment of $505.00 received re 433 Notice of Cross Appeal filed by Lek Pharmaceuticals D.D., Sandoz Inc.. ( Filing fee $505, receipt number ADEDC-3856953.) (Brauerman, Stephen) (Entered: 04/21/2022)
4/21/2022NOTICE OF CROSS APPEAL to the Federal Circuit of 396 Judgment . Cross Appeal filed by Lek Pharmaceuticals D.D., Sandoz Inc.. (Brauerman, Stephen) (Entered: 04/21/2022)
4/20/2022Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): 7,767,225 B2; 7,988,994 B2; 8,383,150 B2; 8,753,679 B2; 7,696,236 B2; 7,767,700 B2; 8,420,674 B2; 7,566,729 B1; 7,635,707 B1; 8,592,462 B2; 8,609,701 B2; 7,816,383 B1; 7,910,610 B1; 8,013,002 B2; 8,084,475 B2; 8,318,780 B2; 8,648,098 B2; 8,754,109 B2; 8,778,947 B2. (Attachments: # 1 Final Judgment)(nms) (Entered: 04/20/2022)
4/19/2022REDACTED VERSION of 415 Declaration by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibits 1-46)(Clark, Cameron) (Entered: 04/19/2022)
4/19/2022REDACTED VERSION of 413 Declaration by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibits A-C)(Clark, Cameron) (Entered: 04/19/2022)
4/19/2022REDACTED VERSION of 412 Reply Brief by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 04/19/2022)
4/19/2022REDACTED VERSION of 414 Declaration by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibit A)(Clark, Cameron) (Entered: 04/19/2022)
4/19/2022ORDER UNSEALING DOCUMENTS: The Muzumdar Declaration and its eight exhibits (D.I. 410 ) are UNSEALED. Signed by Judge Richard G. Andrews on 4/19/2022. (nms) (Entered: 04/19/2022)
4/19/2022CASE CLOSED per entry of D.I. 396 in Lead Civil Action 19-78-RGA. Associated Cases: 1:19-cv-00078-RGA, 1:19-cv-00202-RGA, 1:19-cv-00203-RGA(nms) (Entered: 04/19/2022)
4/18/2022Minute Entry for proceedings held before Judge Richard G. Andrews - Hearing on the Emergency Motion for Temporary Restraining Order and Injunction Pending Appeal held on 4/18/2022. Counsel for Plaintiffs: K. Jacobs. Counsel for Defendants: R. Golden. (Court Reporter Heather Triozzi.) (lak) (Entered: 04/18/2022)
4/18/2022REDACTED VERSION of 410 Declaration of Nimish Muzumdari, by Lek Pharmaceuticals D.D., Sandoz Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Brauerman, Stephen) Modified on 4/18/2022 (nms). (Entered: 04/18/2022)
4/18/2022 DECLARATION of Nimish Muzumdar in Support of Defendants' Redactions (D.I. 407 , 405 , 408 , and 410 ), by Lek Pharmaceuticals D.D., Sandoz Inc.. (Brauerman, Stephen) Modified on 4/18/2022 (nms). (Entered: 04/18/2022)
4/18/2022
  • Order
ORDER: After consideration of the briefing and oral argument, and for the reasons stated in open court, IT IS HEREBY ORDERED this 18th day of April, 2022, that the Emergency Motion for Temporary Restraining Order and Injunction Pending Appeal (D.I. 388 ) is DENIED. Signed by Judge Richard G. Andrews on 4/18/2022. (nms) (Entered: 04/18/2022)
4/18/2022 DECLARATION of Kathleen McGuinness in support of Defendants' Redactions (D.I. 407 , 405 , and 406 ), by Lek Pharmaceuticals D.D., Sandoz Inc.. (Brauerman, Stephen) Modified on 4/18/2022 (nms). (Entered: 04/18/2022)
4/18/2022 DECLARATION of Jocelyn Binet in Support of Defendants' Redactions (D.I. 409 , and 407 ), by Lek Pharmaceuticals D.D., Sandoz Inc.. (Brauerman, Stephen) Modified on 4/18/2022 (nms). (Entered: 04/18/2022)
4/18/2022REDACTED VERSION of 409 Declaration of Mauricio Ede-Filho, by Lek Pharmaceuticals D.D., Sandoz Inc.. (Brauerman, Stephen) Modified on 4/18/2022 (nms). (Entered: 04/18/2022)
4/18/2022REDACTED VERSION of 408 Declaration of Thomas Bongiovanni, by Lek Pharmaceuticals D.D., Sandoz Inc.. (Brauerman, Stephen) Modified on 4/18/2022 (nms). (Entered: 04/18/2022)
4/18/2022REDACTED VERSION of 407 Declaration of David Blackburn, Ph.D., by Lek Pharmaceuticals D.D., Sandoz Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Brauerman, Stephen) Modified on 4/18/2022 (nms). (Entered: 04/18/2022)
4/18/2022REDACTED VERSION of 406 Declaration of Lee Morrow, M.D., by Lek Pharmaceuticals D.D., Sandoz Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Brauerman, Stephen) Modified on 4/18/2022 (nms). (Entered: 04/18/2022)
4/18/2022REDACTED VERSION of 405 Answering Brief in Opposition, by Lek Pharmaceuticals D.D., Sandoz Inc.. (Brauerman, Stephen) (Entered: 04/18/2022)
4/14/2022TRANSCRIPT REQUEST by Genentech, Inc., InterMune, Inc. TRANSCRIPT NOT NEEDED (Clark, Cameron) (Entered: 04/14/2022)
4/12/2022[SEALED] DECLARATION of Christopher A. Vellturo, Ph.D. re 412 Reply Brief, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibits 1-46)(Jacobs, Karen) Modified on 4/13/2022 (nms). (Entered: 04/12/2022)
4/12/2022[SEALED] DECLARATION of Steven D. Nathan, M.D. re 412 Reply Brief, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibit A)(Jacobs, Karen) Modified on 4/13/2022 (nms). (Entered: 04/12/2022)
4/12/2022[SEALED] DECLARATION of Kira A. Davis re 412 Reply Brief, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibits A-C)(Jacobs, Karen) Modified on 4/13/2022 (nms). (Entered: 04/12/2022)
4/12/2022
  • Motion for Temporary Restraining Orderby Π
[SEALED] REPLY BRIEF re 388 EMERGENCY Motion for Temporary Restraining Order and Injunction Pending Appeal filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) (Entered: 04/12/2022)
4/12/2022411
  • Order
ORAL ORDER: A hearing on the Emergency Motion for Temporary Restraining Order and Injunction Pending Appeal (D.I. 388 ) is now set for 4/18/2022, at 3:00 PM in Courtroom 6A. Each side will be limited to 20 minutes. Ordered by Judge Richard G. Andrews on 4/12/2022. (nms) (Entered: 04/12/2022)
4/8/2022DECLARATION of Nimish Muzumdar re 405 Answering Brief in Opposition, by Lek Pharmaceuticals D.D., Sandoz Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Certificate of Service)(Brauerman, Stephen) Modified on 4/11/2022 (nms). Modified on 4/19/2022 (nms). (Entered: 04/08/2022)
4/8/2022[SEALED] DECLARATION of Mauricio Ede-Filho re 405 Answering Brief in Opposition, by Lek Pharmaceuticals D.D., Sandoz Inc.. (Attachments: # 1 Certificate of Service)(Brauerman, Stephen) Modified on 4/11/2022 (nms). (Entered: 04/08/2022)
4/8/2022[SEALED] DECLARATION of Thomas Bongiovanni re 405 Answering Brief in Opposition, by Lek Pharmaceuticals D.D., Sandoz Inc.. (Attachments: # 1 Certificate of Service)(Brauerman, Stephen) Modified on 4/11/2022 (nms). (Entered: 04/08/2022)
4/8/2022[SEALED] DECLARATION of David Blackburn, Ph.D. re 405 Answering Brief in Opposition, by Lek Pharmaceuticals D.D., Sandoz Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Certificate of Service)(Brauerman, Stephen) Modified on 4/11/2022 (nms). (Entered: 04/08/2022)
4/8/2022[SEALED] DECLARATION of Lee Morrow, M.D. re 405 Answering Brief in Opposition, by Lek Pharmaceuticals D.D., Sandoz Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Certificate of Service)(Brauerman, Stephen) Modified on 4/11/2022 (nms). (Entered: 04/08/2022)
4/8/2022
  • Motion for Temporary Restraining Orderby Δ
[SEALED] ANSWERING BRIEF in Opposition re 388 EMERGENCY Motion for Temporary Restraining Order and Injunction Pending Appeal filed by Lek Pharmaceuticals D.D., Sandoz Inc..Reply Brief due date per Local Rules is 4/18/2022. (Attachments: # 1 Certificate of Service)(Brauerman, Stephen) (Entered: 04/08/2022)
4/7/2022 DECLARATION of Ryan Hagglund re 402 Redacted Document, by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) Modified on 4/8/2022 (nms). (Entered: 04/07/2022)
4/7/2022 DECLARATION of Rasika Patankar in support of 400 Redacted Document, 401 Redacted Document, 402 Redacted Document, and 399 Redacted Document, by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) Modified on 4/8/2022 (nms). (Entered: 04/07/2022)
4/7/2022REDACTED VERSION of 393 Declaration, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibits 1-27, # 2 Exhibits 28-35)(Clark, Cameron) (Entered: 04/07/2022)
4/7/2022REDACTED VERSION of 391 Declaration by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 04/07/2022)
4/7/2022REDACTED VERSION of 390 Declaration, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibits 1-4)(Clark, Cameron) (Entered: 04/07/2022)
4/7/2022REDACTED VERSION of 389 Opening Brief in Support, by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 04/07/2022)
4/6/2022CORRECTING ENTRY: The main pdf for D.I. 393 has been replaced with an amended version per counsel's request. Footnote 189 has been added as it was inadverantly omitted. A second certificate has also been added to the filing to confirm service of the amended filing on opposing counsel. (nms) (Entered: 04/06/2022)
4/5/2022NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 397 Notice of Appeal (Federal Circuit), filed by Genentech, Inc., InterMune, Inc.. USCA Case Number 2022-1595. (nms) (Entered: 04/05/2022)
4/1/2022Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 397 Notice of Appeal (Federal Circuit). (mal) (Entered: 04/01/2022)
4/1/2022Notification regarding 397 Notice of Appeal (Federal Circuit) sent to Reporter Triozzi (mal) (Entered: 04/01/2022)
4/1/2022APPEAL - Credit Card Payment of $505.00 received re 397 Notice of Appeal (Federal Circuit) filed by Genentech, Inc., InterMune, Inc.. ( Filing fee $505, receipt number ADEDC-3841029.) (Clark, Cameron) (Entered: 04/01/2022)
4/1/2022 NOTICE OF APPEAL to the Federal Circuit of 396 Judgment . Appeal filed by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 04/01/2022)
4/1/2022CASE NO LONGER REFERRED to Magistrate Judge Fallon for the purpose of exploring ADR. Please see the Court's Standing Order No. 2022-2 dated March 14, 2022. (lih) (Entered: 04/01/2022)
4/1/2022
  • Motion for Judgment
FINAL JUDGMENT (see Judgment for further details). Signed by Judge Richard G. Andrews on 4/1/2022. (nms) (Entered: 04/01/2022)
4/1/2022395
  • Order
ORAL ORDER: Defendants answering brief to the Emergency Motion for Temporary Restraining Order and Injunction Pending Appeal (D.I. 388 ) is due 4/8/2022, and any reply brief is due by 4/12/2022. Ordered by Judge Richard G. Andrews on 4/1/2022. (nms) (Entered: 04/01/2022)
4/1/2022CORRECTING ENTRY: The declaration filed at D.I. 392 has been unsealed per the filer's request. The NEF for the filing will be regenerated. (nms) (Entered: 04/01/2022)
3/31/2022 DECLARATION of Christopher A. Vellturo, Ph.D., Volume 2 of 2, by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) Modified on 4/1/2022 (nms). (Entered: 03/31/2022)
3/31/2022[SEALED] DECLARATION of Christopher A. Vellturo, Ph.D., Volume 1 of 2 re 388 Emergency Motion for Temporary Restraining Order and Injunction Pending Appeal, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibits 1-27, # 2 Exhibits 28-35)(Jacobs, Karen) Modified on 4/1/2022 (nms). (Main Document 393 replaced on 4/6/2022) (nms). (Entered: 03/31/2022)
3/31/2022DECLARATION of Steven D. Nathan, M.D. re 388 Emergency MOTION for Temporary Restraining Order and Injunction Pending Appeal, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibits A-G)(Jacobs, Karen) Modified on 4/1/2022 (nms). Modified on 4/1/2022 (nms). (Entered: 03/31/2022)
3/31/2022[SEALED] DECLARATION of Lisa Chartrand re 388 Emergency Motion for Temporary Restraining Order and Injunction Pending Appeal, by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) Modified on 4/1/2022 (nms). (Entered: 03/31/2022)
3/31/2022[SEALED] DECLARATION of Susan M. Begelman re 388 Emergency Motion for Temporary Restraining Order and Injunction Pending Appeal, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibits 1-4)(Jacobs, Karen) Modified on 4/1/2022 (nms). (Entered: 03/31/2022)
3/31/2022[SEALED] OPENING BRIEF in Support re 388 EMERGENCY Motion for Temporary Restraining Order and Injunction Pending Appeal, filed by Genentech, Inc., InterMune, Inc..Answering Brief/Response due date per Local Rules is 4/14/2022. (Jacobs, Karen) Modified on 4/1/2022 (nms). (Entered: 03/31/2022)
3/31/2022
  • Motion for Temporary Restraining Order
EMERGENCY Motion for Temporary Restraining Order and Injunction Pending Appeal - filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) Modified on 4/1/2022 (nms). (Entered: 03/31/2022)
3/29/2022JOINT Status Report, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibits A-G)(Clark, Cameron) Modified on 3/30/2022 (nms). (Entered: 03/29/2022)
3/22/2022TRIAL OPINION: Plaintiffs have not proven their claim of induced infringement of the Asserted Claims. I further find Sandoz proved the Asserted Claims of the LFT patents are invalid as obvious but did not prove the Asserted Claims of the DDI patents are invalid as obvious. The parties should meet and confer about how to proceed. The parties are asked to submit a status report within one week, preferably with a jointly proposed final judgment (see Opinion for further details). Signed by Judge Richard G. Andrews on 3/22/2022. (nms) (Entered: 03/22/2022)
2/25/2022NOTICE requesting Clerk to remove Nicholas K. Mitrokostas as co-counsel. Reason for request: No longer affiliated with Goodwin Procter, P.A.. (Brauerman, Stephen) (Entered: 02/25/2022)
2/9/2022 Letter to The Honorable Richard G. Andrews, from Cameron P. Clark, enclosing Post-Trial Briefs and Findings of Fact. (Clark, Cameron) Modified on 2/10/2022 (nms). (Entered: 02/09/2022)
2/9/2022CORRECTING ENTRY: The pdfs for D.I. 376 . 381 , 377 , 382 , and the main pdf for D.I. 380 have been replaced with amended versions. Citations to the transcript have corrected. (nms) (Entered: 02/09/2022)
2/2/2022Post-Trial Brief on Infringement and Secondary Considerations, by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) Modified on 2/3/2022 (nms). (Entered: 02/02/2022)
2/2/2022Post-Trial Reply Brief Regarding Invalidity, by Lek Pharmaceuticals D.D., Sandoz Inc.. (Brauerman, Stephen) Modified on 2/3/2022 (nms). (Main Document 382 replaced on 2/9/2022) (nms). (Entered: 02/02/2022)
1/19/2022Proposed Findings of Fact by Lek Pharmaceuticals D.D., Sandoz Inc.. (Brauerman, Stephen) (Main Document 381 replaced on 2/9/2022) (nms). (Entered: 01/19/2022)
1/19/2022POST-TRIAL Answering Brief Regarding Noninfringement and Secondary Considerations, by Lek Pharmaceuticals D.D., Sandoz Inc.. (Attachments: # 1 Exhibit A)(Brauerman, Stephen) Modified on 1/20/2022 (nms). (Main Document 380 replaced on 2/9/2022) (nms). (Entered: 01/19/2022)
1/19/2022Proposed Findings of Fact by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) (Entered: 01/19/2022)
1/19/2022POST-TRIAL Responsive Brief Regarding Validity, by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) Modified on 1/20/2022 (nms). (Entered: 01/19/2022)
12/15/2021Proposed Findings of Fact re 376 Post-Trial Opening Brief Regarding Invalidity, by Lek Pharmaceuticals D.D., Sandoz Inc.. (Brauerman, Stephen) Modified on 12/16/2021 (nms). (Main Document 377 replaced on 2/9/2022) (nms). (Entered: 12/15/2021)
12/15/2021POST-TRIAL Opening Brief Regarding Invalidity, by Lek Pharmaceuticals D.D., Sandoz Inc.. (Brauerman, Stephen) Modified on 12/16/2021 (nms). (Main Document 376 replaced on 2/9/2022) (nms). (Entered: 12/15/2021)
12/15/2021Proposed Findings of Fact in support of 374 Post-Trial Brief on Infringement and Secondary Considerations, by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) Modified on 12/16/2021 (nms). (Entered: 12/15/2021)
12/15/2021POST TRIAL BRIEF on Infringement and Secondary Considerations, by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) Modified on 12/16/2021 (nms). (Entered: 12/15/2021)
12/7/2021CORRECTING ENTRY: The pdf for exhibit 2 found at D.I. 359 has been replaced with a corrected version per counsel's request and opposing counsels' approval. The NEF for the filing has been regenerated. (nms) (Entered: 12/07/2021)
12/1/2021Pro Hac Vice Attorney Kira A. Davis for Genentech, Inc. and InterMune, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) (Entered: 12/01/2021)
11/30/2021
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 369 MOTION for Pro Hac Vice Appearance of Attorney Daralyn J. Durie and Kira A. Davis, filed by Genentech, Inc., InterMune, Inc.. Signed by Judge Richard G. Andrews on 11/30/2021. (nms) (Entered: 11/30/2021)
11/30/2021Official Transcript of Bench Trial held on 11/12/21 before Judge Richard G. Andrews. Court Reporter: Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/21/2021. Redacted Transcript Deadline set for 1/3/2022. Release of Transcript Restriction set for 2/28/2022. (Triozzi, Heather) (Entered: 11/30/2021)
11/30/2021Official Transcript of Bench Trial held on 11/10/21 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/21/2021. Redacted Transcript Deadline set for 1/3/2022. Release of Transcript Restriction set for 2/28/2022. (Triozzi, Heather) (Entered: 11/30/2021)
11/30/2021Official Transcript of Bench Trial held on 11/09/21 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded,uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/21/2021. Redacted Transcript Deadline set for 1/3/2022. Release of Transcript Restriction set for 2/28/2022. (Triozzi, Heather) (Entered: 11/30/2021)
11/30/2021Official Transcript of Bench Trial held on 11/08/21 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/21/2021. Redacted Transcript Deadline set for 1/3/2022. Release of Transcript Restriction set for 2/28/2022. (Triozzi, Heather) (Entered: 11/30/2021)
11/29/2021
  • Motion to Appear Pro Hac Viceby Π
MOTION for Pro Hac Vice Appearance of Attorney Daralyn J. Durie and Kira A. Davis - filed by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 11/29/2021)
11/29/2021Remark: The pdf for D.I. 362 has been replaced per D.I. 367 . (nms) (Entered: 11/29/2021)
11/29/2021SO ORDERED Granting 367 Joint Stipulation to Amend Admitted Trial Exhibits List (D.I. 362) and Proposed Order. Signed by Judge Richard G. Andrews on 11/29/2021. (nms) (Entered: 11/29/2021)
11/24/2021Joint Stipulation to Amend Admitted Trial Exhibits List (D.I. 362) and [Proposed] Order, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Amended Admitted Trial Exhibits)(Clark, Cameron) Modified on 11/29/2021 (nms). (Entered: 11/24/2021)
11/23/2021
  • OrderGranted
SO ORDERED Granting 365 Consent Order of Dismissal in C.A. No. 19-219 (RGA). Signed by Judge Richard G. Andrews on 11/23/2021. (nms) (Entered: 11/23/2021)
11/23/2021Consent Order of Dismissal in C.A. No. 19-219 (RGA), by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) Modified on 11/23/2021 (nms). (Entered: 11/23/2021)
11/18/2021364
  • Motion in Limine
ORAL ORDER: Plaintiffs motion in limine #1 (D.I. 333 ) is RESOLVED as stated at the pretrial conference. (D.I. 341 at 6-17). Ordered by Judge Richard G. Andrews on 11/18/2021. (nms) (Entered: 11/18/2021)
11/18/2021Witness List for Bench Trial held 11/8/21 - 11/10/21, 11/12/21. (lak) (Entered: 11/18/2021)
11/18/2021Exhibit List for Bench Trial held 11/8/21 - 11/10/21, 11/12/21. (lak) (Main Document 362 replaced on 11/29/2021) (nms). (Entered: 11/18/2021)
11/17/2021
  • OrderGranted
SO ORDERED Granting 360 Stipulation and Proposed Order regarding post-trial briefing. Signed by Judge Richard G. Andrews on 11/17/2021. (nms) (Entered: 11/17/2021)
11/16/2021
  • Motionby Π
STIPULATION and [Proposed] Order Regarding Post-Trial Briefing Schedule by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) (Entered: 11/16/2021)
11/12/2021Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial day 4 completed on 11/12/2021. Local Counsel present for Plaintiffs: K. Jacobs. Local Counsel present for Defendant: S. Brauerman. Closing Arguments. (Court Reporter Heather Triozzi.) (lak) (Entered: 11/15/2021)
11/10/2021Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial day 3 held on 11/10/2021. Local Counsel present for Plaintiffs: K. Jacobs. Local Counsel present for Defendant: S. Brauerman. Witnesses: Dr. Steven Nathan, Dr. Rene Levy. (Court Reporter Heather Triozzi.) (lak) (Entered: 11/15/2021)
11/9/2021Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial day 2 held on 11/9/2021. Local Counsel present for Plaintiffs: K. Jacobs. Local Counsel present for Defendant: S. Brauerman. Witnesses: Dr. Lee Morrow, deposition of Dr. Robert Alan Wise, deposition of Dr. Matthew W. McClure, Dr. Paul Ortiz de Montellano, Dr. Steven Duncan, Dr. Andrew Parkinson. (Court Reporter Heather Triozzi.) (lak) (Entered: 11/10/2021)
11/8/2021Minute Entry for proceedings held before Judge Richard G. Andrews - Bench Trial day 1 held on 11/8/2021. Local Counsel present for Plaintiffs: K. Jacobs. Local Counsel present for Defendant: S. Brauerman. Opening Statements made. Witnesses: Dr. Williamson Bradford, deposition of Gregory Seitz, Dr. Steven Nathan, deposition of Isa Samuels, deposition of Javier Szwarcberg (Court Reporter Heather Triozzi.) (lak) (Entered: 11/09/2021)
11/5/2021REDACTED VERSION of 344 Sealed Exhibit 2, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibit 2)(Clark, Cameron) Modified on 11/8/2021 (nms). (Attachment 1 replaced on 12/7/2021) (nms). (Entered: 11/05/2021)
11/5/2021REDACTED VERSION of 332 Sealed Exhibits, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 6, # 3 Exhibit 13)(Clark, Cameron) Modified on 11/5/2021 (nms). (Entered: 11/05/2021)
11/5/2021SECOND REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 332 . (nms) (Entered: 11/05/2021)
11/4/2021REDACTED VERSION of 353 Letter, by Lek Pharmaceuticals D.D., Sandoz Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Brauerman, Stephen) Modified on 11/4/2021 (nms). (Entered: 11/04/2021)
11/3/2021356
  • Order
ORAL ORDER: The redacted filings (D.I. 354 ) is REJECTED because parts of it are redacted in its entirety. Absent a compelling reason, supported by a statement under oath by a party, redactions in their entirety are impermissible; redactions must be done so as to redact the least possible amount of the materials submitted. Failure to make a good faith attempt at such redactions may result in sanctions, the most common of which would be simply unsealing the entire filing. Redacting in its entirety a document that contains publicly available materials is prima facie evidence of bad faith. Revised redacted filings are DUE within five business days. Ordered by Judge Richard G. Andrews on 11/3/2021. (nms) (Entered: 11/03/2021)
11/3/2021355
  • Order
ORAL ORDER: Having considered the letters (D.I. 352 , 353 ), the request for leave to amend and to submit a supplemental expert report is DENIED. The requested last minute activity relates at most to an additional data point for an opinion already expressed by Plaintiffs expert, and is sought simply too close to trial to be justified. Ordered by Judge Richard G. Andrews on 11/3/2021. (nms) (Entered: 11/03/2021)
11/2/2021REDACTED VERSION of 353 Letter by Lek Pharmaceuticals D.D., Sandoz Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Brauerman, Stephen) (Entered: 11/02/2021)
11/1/2021REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 332 . (nms) (Entered: 11/01/2021)
11/1/2021[SEALED] Letter to The Honorable Richard G. Andrews from Stephen B. Brauerman regarding Opposition to Plaintiffs' Motion for Leave. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Certificate of Service)(Brauerman, Stephen) (Entered: 11/01/2021)
10/29/2021 Letter to The Honorable Richard G. Andrews from Karen Jacobs regarding Seeking Leave. (Attachments: # 1 Exhibit A-E)(Jacobs, Karen) (Entered: 10/29/2021)
10/29/2021
  • OrderGranted
SO ORDERED Granting 350 Proposed Consent Order of Dismissal in C.A. Nos. 19-120(RGA) and 19-123 (RGA) (*Party Apotex Corp. and Apotex Inc. terminated). Signed by Judge Richard G. Andrews on 10/29/2021. (nms) (Entered: 10/29/2021)
10/29/2021PROPOSED Consent Order of Dismissal in C.A. Nos. 19-120 (RGA) and 19-123 (RGA), by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) Modified on 10/29/2021 (nms). (Entered: 10/29/2021)
10/27/2021349
  • Order
ORAL ORDER: The Joint Proposed Pretrial Order (D.I. 343 ) is GRANTED as modified. Paragraph 90 was amended by deleting "or closing" in the fourth line. In other words, closing arguments is no counted against the 10.5 hours each side is allotted. Ordered by Judge Richard G. Andrews on 10/27/2021. (nms) (Entered: 10/27/2021)
10/27/2021CORRECTING ENTRY: The main pdf for D.I. 343 has been replaced at the Court's request. Page 18 has been amended. The last sentence on the page has been modifed to remove the words "or closing" after the word opening. The NEF for the filing has been regenerated. (nms) (Entered: 10/27/2021)
10/27/2021REDACTED VERSION of 334 Exhibit to a Document by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 10/27/2021)
10/27/2021REDACTED VERSION of 333 MOTION in Limine #1 by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 10/27/2021)
10/27/2021REDACTED VERSION of 330 Exhibit to a Document by Apotex Corp., Apotex Inc.. (Phillips, John) (Entered: 10/27/2021)
10/27/2021REDACTED VERSION of 329 MOTION in Limine #1 by Apotex Corp., Apotex Inc.. (Phillips, John) (Entered: 10/27/2021)
10/26/2021[SEALED] EXHIBIT 2 to 343 Joint Proposed Pretrial Order, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibit 2)(Clark, Cameron) Modified on 10/27/2021 (nms). (Entered: 10/26/2021)
10/26/2021
  • Motion
Joint Proposed Pretrial Order, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14, # 14 Exhibit 15, # 15 Exhibit 16)(Clark, Cameron) Modified on 10/27/2021 (nms). (Main Document 343 replaced on 10/27/2021) (nms). (Entered: 10/26/2021)
10/26/2021NOTICE of Appearance by Ronald P. Golden, III on behalf of Lek Pharmaceuticals D.D., Sandoz Inc. (Golden, Ronald) (Entered: 10/26/2021)
10/26/2021Official Transcript of Pretrial Conference held on 10/22/21 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 11/16/2021. Redacted Transcript Deadline set for 11/29/2021. Release of Transcript Restriction set for 1/24/2022. (Triozzi, Heather) (Entered: 10/26/2021)
10/25/2021
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 340 MOTION for Pro Hac Vice Appearance of Attorney Daryl Wiesen, filed by Lek Pharmaceuticals D.D., Sandoz Inc.. Signed by Judge Richard G. Andrews on 10/25/2021. (nms) (Entered: 10/25/2021)
10/25/2021
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Daryl Wiesen - filed by Lek Pharmaceuticals D.D., Sandoz Inc.. (Attachments: # 1 [Proposed] Order, # 2 Certification of Daryl Wiesen)(Brauerman, Stephen) (Entered: 10/25/2021)
10/25/2021
  • Order
ORDER Setting Video Mediation Conference: A Video Mediation Conference is set for 10/27/2021 at 10:00 AM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 10/25/2021. (lih) (Entered: 10/25/2021)
10/25/2021
  • OrderGranted
SO ORDERED Granting 337 Stipulation Regarding COVID-19 Protocols. Signed by Judge Richard G. Andrews on 10/25/2021. (nms) (Entered: 10/25/2021)
10/22/2021Minute Entry for proceedings held before Judge Richard G. Andrews - Pretrial Conference held on 10/22/2021. Counsel for Plaintiff: K. Jacobs. Counsel for Defendants: S. Brauerman, J. Phillips. The parties shall submit a revised pretrial order to incorporate the Court's rulings at the pretrial conference. Closing arguments will be held 11/12/2021 at 9:30 AM. (Court Reporter Heather Triozzi.) (lak) (Entered: 10/25/2021)
10/22/2021 STIPULATION Regarding COVID-19 Protocols, by Lek Pharmaceuticals D.D., Sandoz Inc.. (Brauerman, Stephen) Modified on 10/22/2021 (nms). (Entered: 10/22/2021)
10/20/2021
  • OrderGranted
SO ORDERED Granting 335 Consent Order of Dismissal in C.A. Nos. 19-103(RGA) and 19-105 (RGA) (*Party Aurobindo Pharma Limited and Aurobindo Pharma USA Inc. terminated). Signed by Judge Richard G. Andrews on 10/20/2021. (nms) (Entered: 10/20/2021)
10/20/2021Consent PROPOSED ORDER of Dismissal in C.A. Nos. 19-103 (RGA) and 19-105 (RGA) by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 10/20/2021)
10/19/2021[SEALED] EXHIBITS to 333 MOTION in Limine #1, by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) Modified on 10/20/2021 (nms). (Entered: 10/19/2021)
10/19/2021
  • Motion in Limineby Π
[SEALED] MOTION in Limine #1 - filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) (Entered: 10/19/2021)
10/19/2021[SEALED] EXHIBITS to 331 Joint Proposed Pretrial Order, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 6, # 3 Exhibit 13)(Jacobs, Karen) Modified on 10/20/2021 (nms). (Entered: 10/19/2021)
10/19/2021
  • Motion
Joint Proposed Pretrial Order, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 7, # 6 Exhibit 8, # 7 Exhibit 9, # 8 Exhibit 10, # 9 Exhibit 11, # 10 Exhibit 12, # 11 Exhibit 14, # 12 Exhibit 15, # 13 Exhibit 16)(Jacobs, Karen) Modified on 10/20/2021 (nms). (Entered: 10/19/2021)
10/19/2021[SEALED] EXHIBITS to 329 MOTION in Limine #1, by Apotex Corp., Apotex Inc.. (Phillips, John) Modified on 10/20/2021 (nms). (Entered: 10/19/2021)
10/19/2021
  • Motion in Limine
[SEALED] MOTION in Limine #1 - filed by Apotex Corp., Apotex Inc.. (Phillips, John) Modified on 10/20/2021 (nms). (Entered: 10/19/2021)
10/15/2021Pro Hac Vice Attorney Tiffany Mahmood for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) (Entered: 10/15/2021)
10/15/2021328
  • Order
ORAL ORDER: Due to a scheduling conflict the Pretrial Conference set for 10/22/2021, will now commence at 3:30 PM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 10/15/2021. (nms) (Entered: 10/15/2021)
10/15/2021
  • Order
ORDER Setting Video Mediation Conference: A Video Mediation Conference is set for 11/1/2021 at 10:00 AM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 10/15/2021. (lih) (Entered: 10/15/2021)
10/15/2021
  • OrderGranted
SO ORDERED Granting 325 Consent Order of Dismissal in C.A. Nos. 19-109(RGA) and 19-110(RGA) (*Party Lupin Ltd. and Lupin Pharmaceuticals Inc. terminated). Signed by Judge Richard G. Andrews on 10/15/2021. (nms) (Entered: 10/15/2021)
10/14/2021PROPOSED Consent Order of Dismissal in C.A. Nos. 19-109 (RGA) and 19-110 (RGA), by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) Modified on 10/14/2021 (nms). (Entered: 10/14/2021)
10/8/2021 NOTICE of Pursuant to 35 U.S.C. § 282 by Lek Pharmaceuticals D.D., Sandoz Inc. (Brauerman, Stephen) (Entered: 10/08/2021)
10/1/2021NOTICE requesting Clerk to remove Cindy Chang as co-counsel. Reason for request: No longer affiliated with Goodwin Procter LLP. (Brauerman, Stephen) (Entered: 10/01/2021)
9/27/2021Official Transcript of Status Videoconference held on 9/2/21 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 10/18/2021. Redacted Transcript Deadline set for 10/28/2021. Release of Transcript Restriction set for 12/27/2021. (Triozzi, Heather) (Entered: 09/27/2021)
9/23/2021
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 321 MOTION for Pro Hac Vice Appearance of Attorney Tiffany Mahmood, filed by Sandoz Inc.. Signed by Judge Richard G. Andrews on 9/23/2021. (nms) (Entered: 09/23/2021)
9/22/2021
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Tiffany Mahmood - filed by Sandoz Inc.. (Attachments: # 1 [Proposed] Order, # 2 Certification of Tiffany Mahmood)(Brauerman, Stephen) (Entered: 09/22/2021)
9/8/2021
  • OrderGranted
SO ORDERED Granting 319 Consent Stipulation and Order of Dismissal in C.A. No. 19-154-RGA (*Party Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. terminated). Signed by Judge Richard G. Andrews on 9/8/2021. (nms) (Entered: 09/08/2021)
9/2/2021Minute Entry for proceedings held before Judge Richard G. Andrews - Status Conference held on 9/2/2021. Counsel for Plaintiffs: K. Jacobs, C. Clark. Counsel for Defendants: C. Hitch, F. Murphy, J. Phillips, S. Andrade, S. O'Byrne. The transcript of the status conference will serve as the Court's ruling. (Court Reporter Heather Triozzi.) (lak) (Entered: 09/02/2021)
9/1/2021
  • Motion to Dismiss (Demurrer)
STIPULATION of Dismissal, by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) Modified on 9/2/2021 (nms). (Entered: 09/01/2021)
9/1/2021NOTICE of Appearance by Sarah Theresa Andrade on behalf of Lek Pharmaceuticals D.D., Sandoz Inc. (Andrade, Sarah) (Entered: 09/01/2021)
8/31/2021Remark: The public may access the hearing scheduled for 9/2/2021, at 2:00 p.m. by dialing the following phone number: +1 202-503-1666, then enter Conference ID: 218765146#. The dial-in information provides listening capabilities only. (lak) (Entered: 08/31/2021)
8/31/2021Joint Letter to The Honorable Richard G. Andrews from Karen Jacobs regarding case narrowing proposals. (Jacobs, Karen) (Entered: 08/31/2021)
8/25/2021
  • Order
ORDER Setting Video Mediation Conference: A Video Mediation Conference is set for 10/5/2021 at 11:00 AM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 8/25/2021. (lih) (Entered: 08/25/2021)
8/23/2021
  • OrderGranted
SO ORDERED Granting 313 Consent Order of Dismissal in C.A. Nos. 19-130-RGA and 20-624-RGA (*Party Shilpa Medicare Limited terminated). Signed by Judge Richard G. Andrews on 8/23/2021. (nms) (Entered: 08/23/2021)
8/23/2021
  • Order
SO ORDERED, re 312 STIPULATION and Proposed Order Extending Deadline for the parties to serve requests for admission as to admissibility and authentication of documents to August 30, 2021. Signed by Judge Richard G. Andrews on 8/23/2021. (nms) (Entered: 08/23/2021)
8/23/2021314
  • Order
ORAL ORDER: The Status Conference set for 9/2/2021 at 2:00 PM will now be held using Teams. A joint email with the email addresses for all those participating in the conference shall be due to the Court's Case Manager by 4:00 PM on 8/26/2021. Ordered by Judge Richard G. Andrews on 8/23/2021. (lak) (Entered: 08/23/2021)
8/20/2021Consent Order of Dismissal, Genentech, Inc., InterMune, Inc.. (Clark, Cameron) Modified on 8/21/2021 (nms). (Entered: 08/20/2021)
8/20/2021
  • Motion to Extend Timeby Π
STIPULATION TO EXTEND TIME for the parties to serve requests for admission as to admissibility and authentication of documents to August 30, 2021 - filed by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 08/20/2021)
8/19/2021311
  • Order
ORAL ORDER: A Telephone Status Conference is now set for 9/2/2021 at 2:00 PM. The Plaintiff shall coordinate the dial-in information for the call, and file a letter on the docket with such information no later than 48 hours before the call. Ordered by Judge Richard G. Andrews on 8/19/2021. (lak) (Entered: 08/19/2021)
8/16/2021
  • Order
SO ORDERED, Granting 309 Consent Order of Dismissal in C.A. No. 19-136-RGA. Signed by Judge Richard G. Andrews on 8/16/2021. (nms) (Entered: 08/16/2021)
8/12/2021Consent Order of Dismissal, by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) Modified on 8/13/2021 (nms). (Entered: 08/12/2021)
8/12/2021NOTICE requesting Clerk to remove Brandon W. McCune as co-counsel. Reason for request: Clerical Error. (McCune, Brandon) (Entered: 08/12/2021)
8/10/2021307
  • Order
ORAL ORDER: I read the joint letter. (D.I. 306 ). The text of the rule in question (D.Del. LR 30.6) dates back to at least 2010. I doubt that it was new then. So I think it was written before technological advances made remote video depositions from foreign countries possible. I do not think the Rule envisioned three-week intervals in connection with an important technical expert in a patent case with both infringement and invalidity opinions. While I agree that the language of our rule is different than the counterpart in state court, I think the state court rule gives a good idea of what is reasonable. A three week time period which is necessitated by unexpected technological problems is too long for the application of the rule to be reasonable. Thus, with the caveat that Plaintiffs counsel cannot review or discuss with the expert the two to three hours of the deposition already taken, they may otherwise discuss relevant matters with the expert. Ordered by Judge Richard G. Andrews on 8/10/2021. (nms) (Entered: 08/10/2021)
8/9/2021 Letter to The Honorable Richard G. Andrews from Karen Jacobs regarding Williams Deposition. (Jacobs, Karen) (Entered: 08/09/2021)
8/6/2021NOTICE of Appearance by Brandon W. McCune on behalf of Laurus Labs Ltd., Laurus Generics Inc. (McCune, Brandon) (Entered: 08/06/2021)
7/26/2021
  • Motion to Extend Time
SO ORDERED, re 304 STIPULATION TO EXTEND TIME for the parties to complete depositions of experts to August 18, 2021. Signed by Judge Richard G. Andrews on 7/26/2021. (nms) (Entered: 07/26/2021)
7/26/2021
  • Motion to Extend Timeby Π
STIPULATION TO EXTEND TIME for the parties to complete depositions of experts to August 18, 2021 - filed by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 07/26/2021)
7/22/2021Pro Hac Vice Attorney Beth Ashbridge for Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) (Entered: 07/22/2021)
7/20/2021
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 303 MOTION for Pro Hac Vice Appearance of Attorney Beth Ashbridge, filed by Lek Pharmaceuticals D.D., Teva Pharmaceutical USA, Inc., Sandoz Inc.. Signed by Judge Richard G. Andrews on 7/20/2021. (nms) (Entered: 07/20/2021)
7/20/2021
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Beth Ashbridge - filed by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc.. (Attachments: # 1 [Proposed] Order, # 2 Certification of Beth Ashbridge)(Brauerman, Stephen) (Entered: 07/20/2021)
7/16/2021
  • Order
ORDER Setting Video Mediation Conference: A Video Mediation Conference is set for 10/4/2021 at 09:00 AM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 7/15/2021. (lih) (Entered: 07/16/2021)
7/16/2021
  • Order
ORDER Setting Video Mediation Conference: A Video Mediation Conference is set for 10/1/2021 at 09:00 AM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 7/15/2021. (lih) (Entered: 07/16/2021)
6/30/2021NOTICE to Take Deposition of Steven D. Nathan, M.D. on a reasonable date and time mutually agreeable to the parties filed by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 06/30/2021)
6/30/2021NOTICE to Take Deposition of Roger L. Williams, M.D. on a reasonable date and time mutually agreeable to the parties filed by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 06/30/2021)
6/30/2021NOTICE to Take Deposition of Andrew Parkinson PH.D. on a reasonable date and time mutually agreeable to the parties filed by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 06/30/2021)
6/30/2021NOTICE to Take Deposition of Rene H. Levy PH.D. on a reasonable date and time mutually agreeable to the parties filed by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 06/30/2021)
6/28/2021NOTICE to Take Deposition of Stephen F. Amato on a reasonable date and time as may be mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 06/28/2021)
6/28/2021
  • Order
ORDER Setting Video Mediation Conferences: A Video Mediation Conference is set for 9/30/2021 at 10:00 AM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 6/28/2021. (lih) (Entered: 06/28/2021)
6/23/2021NOTICE to Take Deposition of Dr. Paul R. Ortiz de Montellano on a reasonable date and time as may be mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 06/23/2021)
6/23/2021NOTICE to Take Deposition of Lee Morrow, M.D. on a reasonable date and time as may be mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 06/23/2021)
6/23/2021NOTICE to Take Deposition of Deborah A. Jaskot on a reasonable date and time as may be mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 06/23/2021)
6/23/2021NOTICE to Take Deposition of Steven R. Duncan, M.D. on a reasonable date and time as may be mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 06/23/2021)
6/23/2021
  • OrderGranted
SO ORDERED Granting 289 Consent Order of Dismissal in C.A. Nos. 19-190-RGA and 19-195-RGA (*Party Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC, Amneal EU, Limited and Amneal Pharmaceuticals Company GmbH terminated). Signed by Judge Richard G. Andrews on 6/23/2021. (nms) (Entered: 06/23/2021)
6/22/2021 PROPOSED Order of Dismissal, by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) Modified on 6/22/2021 (nms). (Entered: 06/22/2021)
6/21/2021NOTICE OF SERVICE of Reply Expert Report of Dr. Stephen Amato and Reply Expert Report of Steven R. Duncan, MD filed by Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 06/21/2021)
6/21/2021NOTICE OF SERVICE of Reply Expert Report of Dr. Paul R. Ortiz de Montellano filed by Amneal EU, Limited, Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Vrana, Robert) (Entered: 06/21/2021)
6/18/2021NOTICE OF SERVICE of (1) Reply Expert Report of Steven D. Nathan, M.D., (2) Reply Expert Report of Roger L. Williams, M.D., (3) Reply Expert Report of Andrew Parkinson, Ph.D., and (4) Reply Expert Report of Rene H. Levy, Ph.D. filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 06/18/2021)
6/16/2021
  • Order
ORDER Rescheduling Video Mediation Conference: IT IS HEREBY ORDERED that the video mediation conference previously set in this matter for 6/17/2021 at 9:00 AM is RESCHEDULED to 6/23/2021 at 01:00 PM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 6/16/2021. (lih) (Entered: 06/16/2021)
6/15/2021
  • Motion to Refer Case to Mediation
ORAL ORDER- IT IS HEREBY ORDERED that the mediation conference set in this matter for today at 1:30 PM is CANCELLED. Ordered by Judge Sherry R. Fallon on 6/15/2021. (lih) (Entered: 06/15/2021)
6/15/2021NOTICE requesting Clerk to remove Alissa M. Pacchioli as co-counsel. Reason for request: Not longer with Katten law firm. (Haney, Megan) (Entered: 06/15/2021)
6/14/2021
  • Motion to Extend Time
SO ORDERED, re 283 STIPULATION TO EXTEND TIME for Parties to serve Reply Expert Reports to June 18, 2021. Signed by Judge Richard G. Andrews on 6/14/2021. (nms) (Entered: 06/14/2021)
6/11/2021
  • Motion to Extend Timeby Δ
STIPULATION TO EXTEND TIME for Parties to serve Reply Expert Reports to June 18, 2021 - filed by Sandoz Inc., Teva Pharmaceutical USA, Inc.. (Brauerman, Stephen) (Entered: 06/11/2021)
5/17/2021
  • Order
ORDER Rescheduling Video Mediation Conference: IT IS HEREBY ORDERED that the video mediation conference previously set in this matter for 6/17/2021 at 1:30 PM is RESCHEDULED to 6/18/2021 at 10:00 AM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 5/17/2021. (lih) (Entered: 05/17/2021)
5/12/2021NOTICE OF SERVICE of (1) Supplemental Expert Report of Steven D. Nathan, M.D., (2) Supplemental Expert Report of Roger L. Williams, M.D., (3) Supplemental Expert Report of Andrew Parkinson, Ph.D., and (4) Supplemental Expert Report of Rene H. Levy, Ph.D. filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 05/12/2021)
5/12/2021NOTICE OF SERVICE of Responsive Expert Report of Dr. S. Duncan filed by Lupin Ltd., Lupin Pharmaceuticals Inc..(Murphy, Francis) (Entered: 05/12/2021)
5/12/2021NOTICE OF SERVICE of Rebuttal Expert Report of Deborah A. Jaskot on Non-Infringement and Rebuttal Expert Report of Lee Morrow, M.D. on Non-Infringement filed by Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 05/12/2021)
4/30/2021Official Transcript of Discovery Conference held on 4/23/21 before Judge Richard G. Andrews. Court Reporter Deanna Warner,Email: Warnerdeanna@gmail.com. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/21/2021. Redacted Transcript Deadline set for 6/1/2021. Release of Transcript Restriction set for 7/29/2021. (Triozzi, Heather) (Entered: 04/30/2021)
4/28/2021
  • Order
SO ORDERED, re 277 STIPULATION and Proposed Order Extending Certain Deadlines. Signed by Judge Richard G. Andrews on 4/28/2021. (nms) (Entered: 04/28/2021)
4/27/2021STIPULATION and Proposed Order Extending Certain Deadlines - filed by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) Modified on 4/28/2021 (nms). (Entered: 04/27/2021)
4/23/2021REDACTED VERSION of 265 Letter by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibit 1-7)(Clark, Cameron) (Entered: 04/23/2021)
4/23/2021REDACTED VERSION of 266 Letter, by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc.. (Brauerman, Stephen) (Entered: 04/23/2021)
4/23/2021
  • Order
ORDER: Defendants in the above captioned matters having moved for an order precluding Genentech, Inc. and InterMune, Inc. (collectively, Plaintiffs) from introducing new theories concerning objective indicia of obviousness and to compel Plaintiffs to produce invoices concerning Dr. Bradford (D.I. 264 ), and the Court having explained its views on the two motions at a discovery conference on April 23, 2021, IT IS SO ORDERED that: 1. Plaintiffs did not disclose any expert opinions concerning objective indicia of obviousness in their opening expert reports. Defendants may seek further relief, if appropriate, in view of the what Defendants experts actually say in the next round of expert reports. 2. Plaintiffs stated an approximation of the billings to date from Dr. Bradford, with an obligation to supplement with a statement shortly before trial with the total billings to that date and a good faith estimate of what the total billings are likely to be through the conclusion of trial. Signed by Judge Richard G. Andrews on 4/23/2021. (nms) (Entered: 04/23/2021)
4/23/2021
  • Order
ORDER: Plaintiffs Genentech, Inc. and InterMune, Inc. having moved for an order striking certain invalidity theories (D.I. 262 ), and the Court having determined that Plaintiffs motion should be denied, as stated at the discovery conference on April 23, 2021, IT IS SO ORDERED that the motion is DENIED. Signed by Judge Richard G. Andrews on 4/23/2021. (nms) (Entered: 04/23/2021)
4/23/2021Minute Entry for proceedings held before Judge Richard G. Andrews - Discovery Conference held on 4/23/2021. Counsel for Plaintiffs: K. Jacobs, C. Clark. Counsel for Defendants: S. Brauerman, F. Murphy, J. Phillips, A. Gaza. The parties are directed to contact Court staff regarding dates. (Court Reporter Deanna Warner.) (lak) (Entered: 04/23/2021)
4/22/2021CORRECTING ENTRY: The pdf for D.I. 272 has been replaced per filing counsel's request and opposing counsels' approval. The NEF for the filing has been regenerated. (nms) Modified on 4/22/2021 (nms). (Entered: 04/22/2021)
4/21/2021REDACTED VERSION of 264 Letter,, by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc.. (Brauerman, Stephen) (Main Document 272 replaced on 4/22/2021) (nms). (Entered: 04/21/2021)
4/21/2021REDACTED VERSION of 263 Exhibit to a Document by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 04/21/2021)
4/20/2021
  • Order
ORDER Setting Video Mediation Conferences: Video Mediation Conferences are set for 6/17/2021 at 09:00 AM and 01:30 PM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 4/20/2021. (lih) (Entered: 04/20/2021)
4/20/2021
  • Order
ORDER Setting Video Mediation Conference: A Video Mediation Conference is set for 6/16/2021 at 09:00 AM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 4/20/2021. (lih) (Entered: 04/20/2021)
4/20/2021
  • Order
ORDER Setting Video Mediation Conferences: Video Mediation Conferences are set for 6/15/2021 at 09:00 AM and 01:30 PM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 4/20/2021. (lih) (Entered: 04/20/2021)
4/20/2021
  • Order
ORDER Setting Video Mediation Conferences: Video Mediation Conferences are set for 6/14/2021 at 09:00 AM and 01:30 PM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 4/20/2021. (lih) (Entered: 04/20/2021)
4/16/2021[SEALED] Letter to The Honorable Richard G. Andrews, from Stephen B. Brauerman, regarding opposition to Plaintiffs' discovery motion. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Certificate of Service)(Brauerman, Stephen) Modified on 4/18/2021 (nms). (Entered: 04/16/2021)
4/16/2021[SEALED] Letter to The Honorable Richard G. Andrews, from Karen Jacobs, regarding opposition to Defendants' discovery motions. (Attachments: # 1 Exhibits 1-7)(Jacobs, Karen) Modified on 4/16/2021 (nms). (Entered: 04/16/2021)
4/15/2021CORRECTING ENTRY: The pdfs for exhibits H, I, and J at D.I. 264 have been replaced with corrected versions per counsel's request and with opposing counsel's approval. (nms) (Entered: 04/15/2021)
4/14/2021[SEALED] Letter to The Honorable Richard G. Andrews, from Stephen B. Brauerman, regarding discovery motions. (Attachments: # 1 [Proposed] Order, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I, # 11 Exhibit J, # 12 Certificate of Service)(Brauerman, Stephen) Modified on 4/15/2021 (nms). (Attachment 9 replaced on 4/15/2021) (nms). (Attachment 10 replaced on 4/15/2021) (nms). (Attachment 11 replaced on 4/15/2021) (nms). (Entered: 04/14/2021)
4/14/2021[SEALED] EXHIBIT A to 262 Letter, by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) Modified on 4/15/2021 (nms). (Entered: 04/14/2021)
4/14/2021 Letter to The Honorable Richard G. Andrews from Karen Jacobs regarding Request that the Court Strike Defendants' New and Improper Invalidity Contentions. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit B-H)(Jacobs, Karen) (Entered: 04/14/2021)
4/1/2021261
  • Order
ORAL ORDER: The parties have advised that discovery disputes have arisen that require judicial attention. The Court will hold a discover conference on 4/23/2021, at 11:30 AM. In preparation for this conference the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Court's form Patent Scheduling Order (Revised 12/19/2019). The conference will be held using Teams. A joint email with the email addresses for all those participating in the conference shall be due to the Court's Case Manager by 4:00 PM on 4/16/2021. Ordered by Judge Richard G. Andrews on 4/1/2021. (nms) (Entered: 04/01/2021)
2/17/2021NOTICE OF SERVICE of Opening Expert Report of Dr. Paul R. Ortiz de Montellano filed by Amneal EU, Limited, Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Vrana, Robert) (Entered: 02/17/2021)
2/17/2021NOTICE OF SERVICE of Opening Expert Report of Steven R. Duncan, M.d. filed by Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 02/17/2021)
2/17/2021NOTICE OF SERVICE of (1) Opening Expert Report of Steven D. Nathan, M.D. and (2) Opening Expert Report of Roger L. Williams, M.D. filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 02/17/2021)
2/15/2021NOTICE OF SERVICE of (1) Defendants' Corrected Joint Final Invalidity Contentions and (2) this Notice of Service filed by Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 02/15/2021)
2/3/2021NOTICE OF SERVICE of (1) Joint Final Invalidity Contentions and (2) this Notice of Service filed by Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 02/03/2021)
1/29/2021NOTICE OF SERVICE of Defendants' Lupin 2nd supplemental response to interrogatory #5 filed by Lupin Ltd., Lupin Pharmaceuticals Inc..(Murphy, Francis) (Entered: 01/29/2021)
1/22/2021Pro Hac Vice Attorney Ellen Levish for Amneal EU, Limited, Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) (Entered: 01/22/2021)
1/21/2021
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 254 MOTION for Pro Hac Vice Appearance of Attorney Ellen K. Levish, filed by Amneal EU, Limited, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals of New York LLC. Signed by Judge Richard G. Andrews on 1/21/2021. (nms) (Entered: 01/21/2021)
1/21/2021
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Ellen K. Levish - filed by Amneal EU, Limited, Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC. (Vrana, Robert) (Entered: 01/21/2021)
1/13/2021NOTICE OF SERVICE of Plaintiffs' Final Infringement Contentions to Defendants, filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) Modified on 1/14/2021 (nms). (Entered: 01/13/2021)
12/28/2020
  • Order
SO ORDERED, re 252 Stipulation and Proposed Order Extending Certain Deadlines. Signed by Judge Richard G. Andrews on 12/28/2020. (nms) (Entered: 12/28/2020)
12/22/2020
  • Motionby Π
STIPULATION and [Proposed] Order Extending Certain Deadlines by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 12/22/2020)
12/16/2020Pro Hac Vice Attorney Jillian M. Schurr for Apotex Corp. and Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) (Entered: 12/16/2020)
12/15/2020
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 251 MOTION for Pro Hac Vice Appearance of Attorney Jillian M. Schurr, filed by Apotex Inc., Apotex Corp.. Signed by Judge Richard G. Andrews on 12/15/2020. (nms) (Entered: 12/15/2020)
12/15/2020
  • Motion to Appear Pro Hac Vice
MOTION for Pro Hac Vice Appearance of Attorney Jillian M. Schurr - filed by Apotex Corp., Apotex Inc.. (Attachments: # 1Certification)(Haney, Megan) Modified on 12/15/2020 (nms). (Entered: 12/15/2020)
12/9/2020NOTICE of Subpoena of Christopher Rubino, by Apotex Corp., Apotex Inc.. (Attachments: # 1 Exhibit 1)(Haney, Megan) Modified on 12/10/2020 (nms). (Entered: 12/09/2020)
12/7/2020NOTICE OF SERVICE of Responses and Objections to Defendants' Notice of Subpoena to Dusica Babovic-Vuksanovic filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 12/07/2020)
12/4/2020 NOTICE of Reduction of Asserted Claims by Genentech, Inc., InterMune, Inc. (Clark, Cameron) (Entered: 12/04/2020)
12/2/2020NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.s Revised Objections And Responses To Plaintiffs Notice Of Deposition Pursuant To Fed. R. Civ. P. 30(b)(6) filed by Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 12/02/2020)
11/25/2020Pro Hac Vice Attorney Christopher B. Ferenc for Apotex Corp. and Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) (Entered: 11/25/2020)
11/24/2020
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 246 MOTION for Pro Hac Vice Appearance of Attorney Christopher B. Ferenc, filed by Apotex Inc., Apotex Corp.. Signed by Judge Richard G. Andrews on 11/24/2020. (nms) (Entered: 11/24/2020)
11/24/2020
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Christopher B. Ferenc - filed by Apotex Corp., Apotex Inc.. (Attachments: # 1 Certification of Christopher B. Ferenc)(Haney, Megan) (Entered: 11/24/2020)
11/12/2020 NOTICE of Defendants' Notice of Subpoena to Dr. Matthew McClure by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc. (Dorsney, Kenneth) (Entered: 11/12/2020)
11/12/2020NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' Third Set of Common Requests for the Production of Documents and Things and (2) Plaintiffs' Objections and Responses to Defendants' Second Set of Common Interrogatories to Plaintiffs (No. 13) filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 11/12/2020)
11/12/2020
  • Motion to Extend Time
SO ORDERED, re 243 STIPULATION TO EXTEND TIME for Certain Depositions. Signed by Judge Richard G. Andrews on 11/12/2020. (nms) (Entered: 11/12/2020)
11/11/2020
  • Motion to Extend Timeby Π
STIPULATION TO EXTEND TIME for Certain Depositions to December 18, 2020 - filed by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 11/11/2020)
11/6/2020
  • OrderGranted
SO ORDERED Granting 241 Stipulation and [Proposed] Order Regarding Remote Depositions. Signed by Judge Richard G. Andrews on 11/6/2020. (nms) (Entered: 11/06/2020)
11/6/2020
  • Motionby Π
STIPULATION and [Proposed] Order Regarding Remote Depositions by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 11/06/2020)
11/4/2020
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 240 MOTION for Pro Hac Vice Appearance of Attorney Nicholas K. Mitrokostas, filed by Lek Pharmaceuticals D.D., Teva Pharmaceutical USA, Inc., Sandoz Inc.. Signed by Judge Richard G. Andrews on 11/4/2020. (nms) (Entered: 11/04/2020)
11/3/2020
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Nicholas K. Mitrokostas - filed by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc.. (Attachments: # 1 Certification of Nicholas K. Mitrokostas)(Brauerman, Stephen) (Entered: 11/03/2020)
11/3/2020Pro Hac Vice Attorney Tara R. Melillo for Lek Pharmaceuticals D.D., Sandoz Inc. and Teva Pharmaceutical USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) (Entered: 11/03/2020)
10/30/2020
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 239 MOTION for Pro Hac Vice Appearance of Attorney Tara R. Melillo, filed by Lek Pharmaceuticals D.D., Teva Pharmaceutical USA, Inc., Sandoz Inc.. Signed by Judge Richard G. Andrews on 10/30/2020. (nms) (Entered: 10/30/2020)
10/30/2020
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Tara R. Melillo - filed by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc.. (Attachments: # 1 Certification of Tara R. Melillo)(Brauerman, Stephen) (Entered: 10/30/2020)
10/30/2020Pro Hac Vice Attorney Kathleen A. McGuinness for Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) (Entered: 10/30/2020)
10/29/2020 NOTICE of Service of Lupin Ltd. and Lupin Pharmaceuticals, Inc.s Objections and Responses to Plaintiffs Notice of Deposition under FRCP 30(b)(6) to Lupin by Lupin Ltd., Lupin Pharmaceuticals Inc. (Murphy, Francis) (Entered: 10/29/2020)
10/29/2020CORRECTING ENTRY: The main pdf for D.I. 237 has been replaced with an amended version per counsel's request. Signatures for all signers has been updated. The NEF for the filing has been regenerated. (nms) (Entered: 10/29/2020)
10/28/2020 NOTICE of Subpoena of Dusica Babovic-Vuksanovic by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc. (Attachments: # 1 Exhibit A)(Brauerman, Stephen) (Main Document 237 replaced on 10/29/2020) (nms). (Entered: 10/28/2020)
10/28/2020NOTICE OF SERVICE of Defendant Sandoz, Inc. and LEK Pharmaceuticals D.D.'s Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Lek Pharmaceuticals D.D., Sandoz Inc..(Brauerman, Stephen) (Entered: 10/28/2020)
10/27/2020NOTICE OF SERVICE of Defendant Teva Pharmaceutical USA, Inc.s Objections and Responses to Plaintiffs Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 10/27/2020)
10/27/2020NOTICE OF SERVICE of Apotex's Responses and Objections to Plaintiffs' Notice of Deposition Under FRCP 30(b)(6) to Apotex Inc. and Apotex Corp. filed by Apotex Corp., Apotex Inc..(Haney, Megan) (Entered: 10/27/2020)
10/27/2020NOTICE OF SERVICE of Shilpa Medicare Limited's Privilege Log filed by Shilpa Medicare Limited.(Ormerod, Eve) (Entered: 10/27/2020)
10/23/2020NOTICE to Take Deposition of Greg Seitz on a reasonable date and time as may be mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/23/2020)
10/23/2020NOTICE to Take Deposition of Bina Merai on a reasonable date and time as may be mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/23/2020)
10/23/2020NOTICE to Take Deposition of Anthony Maffia on a reasonable date and time as may be mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/23/2020)
10/21/2020 NOTICE of Subpoena of Williamson Ziegler Bradford by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc. (Attachments: # 1 Exhibit 1)(Brauerman, Stephen) (Entered: 10/21/2020)
10/21/2020 NOTICE of Subpoena of Javier Szwarcberg by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc. (Attachments: # 1 Exhibit 1)(Brauerman, Stephen) (Entered: 10/21/2020)
10/21/2020NOTICE OF SERVICE of Objections and Responses to Plaintiffs Notice of Deposition Under FRCP 30(b)(6) filed by Shilpa Medicare Limited.(Belgam, Neal) (Entered: 10/21/2020)
10/20/2020
  • Order
MEMORANDUM ORDER providing claim construction for a single term in U.S. Patent Nos. 7,566,729, 7,635,707, and 8,592,462. Plaintiffs' proposed construction is adopted. Signed by Judge Richard G. Andrews on 10/20/2020. (nms) (Entered: 10/20/2020)
10/19/2020
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 225 MOTION for Pro Hac Vice Appearance of Attorney Kathleen McGuinness, filed by Lek Pharmaceuticals D.D., Teva Pharmaceutical USA, Inc., Sandoz Inc.. Signed by Judge Richard G. Andrews on 10/19/2020. (nms) (Entered: 10/19/2020)
10/16/2020
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Kathleen McGuinness - filed by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc.. (Attachments: # 1 Certification of Kathleen McGuinness)(Brauerman, Stephen) (Entered: 10/16/2020)
10/16/2020NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/16/2020)
10/15/2020NOTICE OF SERVICE of (1) Aurobindo's Objections to Plaintiffs' Notice of 30(b)(6) Deposition; (2) Aurobindo's Privilege Log (capsules); and (3) Aurobindo's Privilege Log (tablets) filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Dorsney, Kenneth) (Entered: 10/15/2020)
10/14/2020NOTICE OF SERVICE of Defendants Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals Company GMBH, and Amneal EU, Ltd.s Objections and Responses to Plaintiffs Notice of Deposition Under FRCP 30(b)(6) filed by Amneal EU, Limited, Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Vrana, Robert) (Entered: 10/14/2020)
10/14/2020NOTICE to Take Deposition of David DeCicco on November 12, 2020 filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/14/2020)
10/14/2020NOTICE to Take Deposition of Cristina Morales on a date and time mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/14/2020)
10/14/2020NOTICE to Take Deposition of Craig Jones on a date and time mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/14/2020)
10/14/2020NOTICE to Take Deposition of Renata Degady on a date and time mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/14/2020)
10/14/2020NOTICE to Take Deposition of Melissa Henry on a date and time mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/14/2020)
10/14/2020NOTICE to Take Deposition of Mateja Sikovec on a date and time mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/14/2020)
10/14/2020NOTICE to Take Deposition of Pramod Dahibhate on a date and time mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/14/2020)
10/14/2020NOTICE to Take Deposition of Jason Gensburger on a date and time mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/14/2020)
10/14/2020NOTICE to Take Deposition of Anant Borgaonkar on a date and time mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/14/2020)
10/14/2020NOTICE to Take Deposition of Radhika Dasari on a date and time mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/14/2020)
10/14/2020NOTICE to Take Deposition of Nilesh Bhandari on a date and time mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/14/2020)
10/14/2020NOTICE to Take Deposition of Debashis Dash on a date and time mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/14/2020)
10/14/2020NOTICE to Take Deposition of Sonya DaCosta on a date and time mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/14/2020)
10/14/2020NOTICE to Take Deposition of Cristina de Lima on a date and time mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/14/2020)
10/14/2020NOTICE to Take Deposition of Betty Wong on a date and time mutually agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/14/2020)
10/14/2020CORRECTING ENTRY: The docket text for D.I. 203 has been amended to match that listed on the title of the document. (nms) (Entered: 10/14/2020)
10/13/2020NOTICE OF SERVICE of Defendants' Third Set of Common Requests for the Production of Documents and Things and Defendants' Second Set of Common Interrogatories filed by Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 10/13/2020)
10/13/2020 NOTICE of Subpoena to Robert Wise, M.D. by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc. (Attachments: # 1 Exhibit 1)(Brauerman, Stephen) (Entered: 10/13/2020)
10/13/2020 NOTICE of Subpoena of Michael Grippi M.D. by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc. (Attachments: # 1 Exhibit 1)(Brauerman, Stephen) (Entered: 10/13/2020)
10/13/2020NOTICE of Subpoena of Charles Davis, M.D. by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc.. (Attachments: # 1 Exhibit 1)(Brauerman, Stephen) Modified on 10/13/2020 (nms). (Entered: 10/13/2020)
10/13/2020 NOTICE of Subpoena of Jeff Loutit M.D. by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc. (Attachments: # 1 Exhibit 1)(Brauerman, Stephen) (Entered: 10/13/2020)
10/8/2020Official Transcript of Markman Hearing Videoconference held on 9/23/20 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 10/29/2020. Redacted Transcript Deadline set for 11/9/2020. Release of Transcript Restriction set for 1/6/2021. (Triozzi, Heather) (Entered: 10/08/2020)
10/6/2020NOTICE to Take Deposition of Lin Pan, Ph. D. on a date and time mutually agreeable to the parties filed by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 10/06/2020)
10/6/2020NOTICE to Take Deposition of Isa Samuels on a date and time mutually agreeable to the parties filed by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 10/06/2020)
10/6/2020NOTICE to Take Deposition of Javier Szwarcberg on a date and time mutually agreeable to the parties filed by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 10/06/2020)
10/6/2020NOTICE to Take Deposition of Williamson Ziegler Bradford on a date and time mutually agreeable to the parties filed by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 10/06/2020)
10/6/2020NOTICE to Take Deposition of Christopher Rubino on a date and time mutually agreeable to the parties filed by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 10/06/2020)
10/5/2020NOTICE OF SERVICE of Sandoz Inc. and LEK Pharmaceuticals D.D.'s Privilege Log filed by Lek Pharmaceuticals D.D., Sandoz Inc..(Brauerman, Stephen) (Entered: 10/05/2020)
10/5/2020NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc.'s Privilege Log filed by Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 10/05/2020)
10/5/2020NOTICE OF SERVICE of Amneal Pharmaceuticals LLC et al.'s Privilege Log and Attorney List filed by Amneal EU, Limited, Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Vrana, Robert) (Entered: 10/05/2020)
10/5/2020NOTICE OF SERVICE of Lupin LTD and Lupin Pharmaceuticals, Inc.'s Privilege Log filed by Lupin Ltd., Lupin Pharmaceuticals Inc..(Parshall, Jonathan) (Entered: 10/05/2020)
10/5/2020NOTICE OF SERVICE of Apotex's Privilege Log filed by Apotex Corp., Apotex Inc..(Haney, Megan) (Entered: 10/05/2020)
10/2/2020NOTICE to Take Deposition of Shilpa defendant (under 30(b)(6) on date and time to be agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/02/2020)
10/2/2020NOTICE to Take Deposition of Amneal Defendants (under 30(b)(6)) on a date and time agreeable to the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/02/2020)
10/2/2020NOTICE OF SERVICE of Plaintiffs' Privilege Log filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/02/2020)
10/2/2020
  • Motion to Extend Time
SO ORDERED, re 187 STIPULATION TO EXTEND TIME Produce Privilege Logs to October 16, 2020. Signed by Judge Richard G. Andrews on 10/2/2020. (nms) (Entered: 10/02/2020)
10/1/2020
  • Motion to Extend Timeby Δ
STIPULATION TO EXTEND TIME Produce Privilege Logs to October 16, 2020 - filed by Aurobindo Pharma Limited. (Dorsney, Kenneth) (Entered: 10/01/2020)
10/1/2020NOTICE to Take Deposition of Teva Pharmaceuticals USA, Inc. on a date and time to be agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/01/2020)
10/1/2020NOTICE to Take Deposition of Sandoz, Inc. and Lek Pharmaceuticals d.d. on a date and time to be agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/01/2020)
10/1/2020NOTICE to Take Deposition of Lupin Ltd. and Lupin Pharmaceuticals, Inc. on a date and time to be agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/01/2020)
10/1/2020NOTICE to Take Deposition of Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. on a date and time to be agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/01/2020)
10/1/2020NOTICE to Take Deposition of Apotex Inc. and Apotex Corp. on a date and time to be agreed upon by the parties filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 10/01/2020)
9/30/2020REDACTED VERSION of 180 Notice to Take Deposition, by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc.. (Brauerman, Stephen) (Entered: 09/30/2020)
9/30/2020[SEALED] NOTICE to Take Deposition of Plaintiffs Genentech, Inc. and InterMune Inc. on a date and time mutually agreeable to the parties filed by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc.. (Attachments: # 1 Certificate of Service)(Brauerman, Stephen) (Entered: 09/30/2020)
9/29/2020REDACTED VERSION of 175 Notice to Take Deposition, by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc.. (Brauerman, Stephen) (Entered: 09/29/2020)
9/29/2020REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 175 . (nms) (Entered: 09/29/2020)
9/25/2020NOTICE OF SERVICE of Supplemental Response to Plaintiffs' First Set of Interrogatories filed by Shilpa Medicare Limited.(Ormerod, Eve) (Entered: 09/25/2020)
9/23/2020Minute Entry for proceedings held before Judge Richard G. Andrews - Markman Hearing held on 9/23/2020. Counsel for Plaintiffs: K. Jacobs, C. Clark. Counsel for Defendants: S. Brauerman. (Court Reporter Heather Triozzi.) (lak) (Entered: 09/23/2020)
9/21/2020NOTICE OF SERVICE of (1) Joint Supplemental Invalidity Contentions and (2) this Notice of Service filed by Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 09/21/2020)
9/21/2020176
  • Motion for Claim Construction
ORAL ORDER: The Markman Hearing set for 9/23/2020, will now commence at 9:30 AM. Ordered by Judge Richard G. Andrews on 9/21/2020. (nms) (Entered: 09/21/2020)
9/18/2020[SEALED] NOTICE to Take Deposition of Plaintiffs Genentech, Inc. and InterMune Inc. on a date and time mutually agreeable to the parties filed by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc.. (Attachments: # 1 Certificate of Service)(Brauerman, Stephen) (Entered: 09/18/2020)
9/18/2020Remark: The dial-in information for the Markman hearing scheduled for September 23, 2020 via Skype for Business is as follows: 1-202-503-1666. Code: 635390336# (lak) (Entered: 09/18/2020)
9/16/2020
  • OrderGranted
SO ORDERED Granting 173 Stipulation and Order Regarding Discovery and Infringement. Signed by Judge Richard G. Andrews on 9/16/2020. (nms) (Entered: 09/16/2020)
9/16/2020STIPULATION and Order Regarding Discovery and Infringement, by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) Modified on 9/16/2020 (nms). (Entered: 09/16/2020)
9/10/2020
  • Motion to StayGranted
SO ORDERED Granting 171 Stipulation and Proposed Order Staying Action regarding defendants Invagen Pharmaceuticals, Inc. and Cipla USA, Inc.. Signed by Judge Richard G. Andrews on 9/10/2020. (nms) (Entered: 09/10/2020)
9/9/2020STIPULATION and Proposed Order Staying Action, by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) Modified on 9/10/2020 (nms). (Entered: 09/09/2020)
9/2/2020170
  • Motion for Claim Construction
ORAL ORDER: The Markman hearing scheduled for September 23, 2020, will be held using Skype for business. A joint email with the email addresses for all those participating in the hearing shall be due to the Court's Case Manager by 4:00 PM on 9/16/2020. Ordered by Judge Richard G. Andrews on 9/2/2020. (nms) (Entered: 09/02/2020)
8/31/2020NOTICE OF SERVICE of (1) Defendant Teva Pharmaceuticals USA, Inc.'s First Supplemental Objections and Responses To Plaintiffs' First Set Of Interrogatories (Nos. 1-9) and (2) this Notice of Service filed by Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 08/31/2020)
8/31/2020NOTICE OF SERVICE of (1) Defendant Sandoz Inc. and Lek Pharmaceuticals D.D.'s First Supplemental Objections and Responses To Plaintiffs' First Set Of Interrogatories (Nos. 1-9) and (2) this Notice of Service filed by Sandoz Inc..(Brauerman, Stephen) (Entered: 08/31/2020)
8/31/2020NOTICE OF SERVICE of Plaintiffs' First Supplemental Objections and Responses to Defendant's First Set of Common Interrogatories to Plaintiffs (Nos. 1-12) filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 08/31/2020)
8/31/2020NOTICE OF SERVICE of Apotex's Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories (No. 5) filed by Apotex Corp., Apotex Inc..(Haney, Megan) (Entered: 08/31/2020)
8/31/2020NOTICE OF SERVICE of Supplemental response to interrogatory No. 5 filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Dorsney, Kenneth) (Entered: 08/31/2020)
8/31/2020NOTICE OF SERVICE of Lupin LTD. and Lupin Pharmaceuticals, INC.S First Supplemental Response to Plaintiffs Interrogatory NO. 5 filed by Lupin Ltd., Lupin Pharmaceuticals Inc..(Murphy, Francis) (Entered: 08/31/2020)
8/28/2020NOTICE OF SERVICE of Plaintiffs' Amended Rule 26(a)(1) Initial Disclosures (directed to various defendants as outlined in notice) filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 08/28/2020)
8/27/2020 APPENDIX, Volume 3 of 3 re 156 Joint Claim Construction Brief, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibits 32-55)(Clark, Cameron) Modified on 8/27/2020 (nms). (Entered: 08/27/2020)
8/27/2020APPENDIX, Volume 2 of 3 re 156 Joint Claim Construction Brief, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibits 11-23, # 2 Exhibits 24-31)(Clark, Cameron) Modified on 8/27/2020 (nms). (Entered: 08/27/2020)
8/27/2020 APPENDIX Volume 1 of 3 re 156 Joint Claim Construction Brief, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibits 1-7, # 2 Exhibit 8, # 3 Exhibit 9 part 1, # 4 Exhibit 9 part 2 and Exhibit 10)(Clark, Cameron) Modified on 8/27/2020 (nms). (Entered: 08/27/2020)
8/27/2020
  • Motion to StayGranted
SO ORDERED Granting 158 Stipulation and Proposed Order Staying Action. Signed by Judge Richard G. Andrews on 8/27/2020. (nms) (Entered: 08/27/2020)
8/27/2020CORRECTING ENTRY: The appendix filed at D.I. 157 has been removed from the docket. Counsel will refile the appendix as a multi-volume set. (nms) (Entered: 08/27/2020)
8/27/2020STIPULATION and Proposed Order Staying Action, by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) Modified on 8/27/2020 (nms). (Entered: 08/27/2020)
8/27/2020
  • Motion for Claim ConstructionGranted
SO ORDERED, Granting 155 Joint Motion for Claim Construction. Ordered by Judge Richard G. Andrews on 8/27/2020. (nms) (Entered: 08/27/2020)
8/26/2020Joint Claim Construction Brief, filed by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) Modified on 8/27/2020 (nms). (Entered: 08/26/2020)
8/26/2020Joint Motion for Claim Construction - filed by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) Modified on 8/27/2020 (nms). (Entered: 08/26/2020)
8/19/2020NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief filed by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 08/19/2020)
8/18/2020
  • Order
SO ORDERED, re 153 STIPULATION to Modify Deadline (*substantial completion of document production due by 8/31/2020). Signed by Judge Richard G. Andrews on 8/18/2020. (nms) (Entered: 08/18/2020)
8/17/2020
  • Motion
STIPULATION to Modify Deadline - filed by Cipla USA Inc., InvaGen Pharmaceuticals Inc.. (Moore, David) Modified on 8/18/2020 (nms). (Entered: 08/17/2020)
8/5/2020Official Transcript of Discovery Videoconference held on 7/20/20 before Judge Richard G. Andrews. Court Reporter Jennifer Guy,Email: Jenniferguyrpr@gmail.com. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/26/2020. Redacted Transcript Deadline set for 9/8/2020. Release of Transcript Restriction set for 11/3/2020. (Triozzi, Heather) (Entered: 08/05/2020)
7/29/2020NOTICE OF SERVICE of (1) Plaintiffs' Reply Claim Construction Brief; and (2) Declaration of Steven D. Nathan, M.D. in Support of Intermune's Claim Construction Reply Brief filed by Genentech, Inc., InterMune, Inc..(Jacobs, Karen) (Entered: 07/29/2020)
7/28/2020
  • Order
SO ORDERED, re 149 Stipulation and Order Regarding Discovery and Infringement. Signed by Judge Richard G. Andrews on 7/28/2020. (nms) (Entered: 07/28/2020)
7/28/2020 STIPULATION and Order Regarding Discovery and Infringement by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 07/28/2020)
7/20/2020REDACTED VERSION of 144 Declaration by Teva Pharmaceutical USA, Inc.. (Brauerman, Stephen) (Entered: 07/20/2020)
7/20/2020REDACTED VERSION of 143 Letter, by Teva Pharmaceutical USA, Inc.. (Attachments: # 1 Exhibit A-B, # 2 Exhibit C, # 3 Exhibit D-1, # 4 Exhibit D-2, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G-H)(Brauerman, Stephen) (Entered: 07/20/2020)
7/20/2020Minute Entry for proceedings held before Judge Richard G. Andrews - Discovery Conference held on 7/20/2020. Local counsel for plaintiffs: K. Jacobs. Local counsel for defendants: S. Brauerman. (Court Reporter Jennifer Guy.) (crb) (Entered: 07/20/2020)
7/16/2020REDACTED VERSION of 142 Letter, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibit 1-31, # 2 Text of Proposed Order)(Clark, Cameron) (Entered: 07/16/2020)
7/16/2020CORRECTING ENTRY: The redacted document filed at D.I. 146 has been removed from the docket per counsel's request as the filing was incomplete. (nms) (Entered: 07/16/2020)
7/15/2020145
  • Order
ORAL ORDER: Due to a scheduling conflict the discovery conference set for 7/20/2020, will now be held at 9:00 AM. Ordered by Judge Richard G. Andrews on 7/15/2020. (nms) (Entered: 07/15/2020)
7/13/2020[SEALED] DECLARATION of Victor J. Thannickal, M.D. re 143 Letter, by Teva Pharmaceutical USA, Inc.. (Attachments: # 1 Certificate of Service)(Brauerman, Stephen) Modified on 7/14/2020 (nms). (Entered: 07/13/2020)
7/13/2020[SEALED] Letter to The Honorable Richard G. Andrews from Stephen B. Brauerman regarding Opposing Disqualification of Defendants Expert, Dr. Victor Thannickal. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit D-2, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Certificate of Service)(Brauerman, Stephen) (Entered: 07/13/2020)
7/9/2020[SEALED] Letter to The Honorable Richard G. Andrews from Jack B. Blumenfeld regarding disqualification of defendants' expert, Dr. Victor Thannickal. (Attachments: # 1 Text of Proposed Order, # 2 Exhibits 1-16, # 3 Exhibit 17, # 4 Exhibit 18, # 5 Exhibits 19-31)(Blumenfeld, Jack) (Entered: 07/09/2020)
7/9/2020
  • Order
SO ORDERED, re 140 Stipulation to Modify Deadline. Signed by Judge Richard G. Andrews on 7/9/2020. (nms) (Entered: 07/09/2020)
7/9/2020
  • Order
SO ORDERED, re 139 Stipulation to Modify Deadline. Signed by Judge Richard G. Andrews on 7/9/2020. (nms) (Entered: 07/09/2020)
7/9/2020
  • Order
SO ORDERED, re 138 Stipulation to Modify Deadline. Signed by Judge Richard G. Andrews on 7/9/2020. (nms) (Entered: 07/09/2020)
7/9/2020
  • Order
SO ORDERED, re 137 Stipulation to Modify Deadline. Signed by Judge Richard G. Andrews on 7/9/2020. (nms) (Entered: 07/09/2020)
7/9/2020
  • Order
SO ORDERED, re 136 Stipulation to Modify Deadline. Signed by Judge Richard G. Andrews on 7/9/2020. (nms) (Entered: 07/09/2020)
7/9/2020
  • Order
SO ORDERED, re 135 Stipulation to Modify Deadline. Signed by Judge Richard G. Andrews on 7/9/2020. (nms) (Entered: 07/09/2020)
7/8/2020NOTICE OF SERVICE of (1) Defendants Responsive Claim Construction Brief and (2) this Notice of Service filed by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 07/08/2020)
7/8/2020
  • Motionby Π
STIPULATION to Modify Deadline by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 07/08/2020)
7/8/2020
  • Motionby Π
STIPULATION to Modify Deadline by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 07/08/2020)
7/8/2020
  • Motionby Δ
STIPULATION to Modify Deadline by Teva Pharmaceutical USA, Inc.. (Brauerman, Stephen) (Entered: 07/08/2020)
7/8/2020
  • Motionby Δ
STIPULATION To Modify Deadline by Lek Pharmaceuticals D.D., Sandoz Inc.. (Brauerman, Stephen) (Entered: 07/08/2020)
7/8/2020
  • Motionby Π
STIPULATION to Modify Deadline by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 07/08/2020)
7/8/2020
  • Motionby Π
STIPULATION to Modify Deadline by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 07/08/2020)
7/8/2020
  • Order
SO ORDERED, re 134 Stipulation to Modify Deadline. Signed by Judge Richard G. Andrews on 7/8/2020. (nms) (Entered: 07/08/2020)
7/8/2020
  • Motionby Π
STIPULATION to Modify Deadline by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 07/08/2020)
7/7/2020REDACTED VERSION of 127 Stipulation by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 07/07/2020)
7/7/2020Pro Hac Vice Attorney Neal Seth for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) (Entered: 07/07/2020)
7/6/2020NOTICE requesting Clerk to remove Gurpreet S. Walia and Gary Ji as co-counsel.. (Haney, Megan) (Entered: 07/06/2020)
7/6/2020
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 131 MOTION for Pro Hac Vice Appearance of Attorney Neal Seth, filed by Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc.. Signed by Judge Richard G. Andrews on 7/6/2020. (nms) (Entered: 07/06/2020)
7/6/2020
  • Motion to Appear Pro Hac Vice
MOTION for Pro Hac Vice Appearance of Attorney Neal Seth - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Attachments: # 1 Certification)(Haney, Megan) Modified on 7/6/2020 (nms). (Entered: 07/06/2020)
7/6/2020CORRECTING ENTRY: The pro hac motion filed at D.I. 131 has been removed from the docket per counsel's request. A complete version of the motion will be refiled. (nms) (Entered: 07/06/2020)
7/2/2020130
  • Order
ORAL ORDER: The parties have advised that a dispute has arisen requiring judicial attention. The Court will hold a discovery conference on 7/20/2020, at 2:00 PM before Judge Richard G. Andrews to take up this issue. In preparation for this conference the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Court's form Patent Scheduling Order (Revised 12/19/2019). The hearing will be held using Skype for business. A joint email with the email addresses for all those participating in the conference shall be due to the Court's Case Manager by 4:00 PM on 7/13/2020. Ordered by Judge Richard G. Andrews on 7/2/2020. (nms) (Entered: 07/02/2020)
7/2/2020
  • Order
SO ORDERED, re 129 Stipulation to Modify Deadline. Signed by Judge Richard G. Andrews on 7/2/2020. (nms) (Entered: 07/02/2020)
7/2/2020
  • Motion
STIPULATION to Modify Deadline, by Lupin Ltd., Lupin Pharmaceuticals Inc.. (Parshall, Jonathan) Modified on 7/2/2020 (nms). (Entered: 07/02/2020)
7/1/2020
  • OrderGranted
[SEALED] ORDER Granting 127 Sealed Stipulation and Proposed Order to Joint Party. Signed by Judge Richard G. Andrews on 7/1/2020.This order has been emailed to local counsel. (nms) (Entered: 07/01/2020)
6/30/2020
  • Motionby Π
[SEALED] STIPULATION and [Proposed] Order to Join Party by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 06/30/2020)
6/18/2020
  • Order
SO ORDERED, re 126 Stipulation to Modify Deadline. Signed by Judge Richard G. Andrews on 6/18/2020. (nms) (Entered: 06/18/2020)
6/18/2020
  • Motion
STIPULATION to Modify Deadline, by Cipla USA Inc.. (Palapura, Bindu) Modified on 6/18/2020 (nms). (Entered: 06/18/2020)
6/15/2020NOTICE OF SERVICE of Plaintiffs' Supplemental Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 06/15/2020)
6/15/2020NOTICE OF SERVICE of (1) Plaintiffs' Initial Claim Charts Shilpa 267 and 801 MG Tablets, (2) Plaintiffs' Rule 26(a)(1) Initial Disclosures, and (3) Plaintiffs' Paragraph 4(a) Disclosures filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 06/15/2020)
6/4/2020
  • OrderGranted
SO ORDERED Granting (122 in 19-cv-78-RGA; 11 in 20-cv-624-RGA) Stipulation and Order for Consolidation. Signed by Judge Richard G. Andrews on 6/4/2020. Associated Cases: 1:19-cv-00078-RGA, 1:20-cv-00624-RGA(nms) (Entered: 06/04/2020)
6/3/2020Proposed Stipulation and Order for Consolidation, by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) Modified on 6/4/2020 (nms). (Entered: 06/03/2020)
6/3/2020NOTICE OF SERVICE of Plaintiffs' Opening Brief on Claim Construction filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 06/03/2020)
5/20/2020NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc.s Supplemental Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery and Teva Pharmaceuticals USA, Inc.s Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) filed by Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 05/20/2020)
5/8/2020Joint Claim Construction Chart, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibits 1-7, # 2 Exhibit 8, # 3 Exhibit 9 part 1, # 4 Exhibit 9 part 2 - 10)(Clark, Cameron) Modified on 5/11/2020 (nms). (Entered: 05/08/2020)
5/8/2020Pro Hac Vice Attorneys George J. Barry, III and Timothy H. Kratz for Aurobindo Pharma Limited and Aurobindo Pharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) (Entered: 05/08/2020)
5/7/2020
  • Order
SO ORDERED, re 118 STIPULATION and Order to submit the Joint Claim Construction Chart by May 8, 2020. Signed by Judge Richard G. Andrews on 5/7/2020. (nms) (Entered: 05/07/2020)
5/6/2020STIPULATION and Proposed Order to Submit Joint Claim Construction Chart to May 8, 2020 - filed by Sandoz Inc., Teva Pharmaceutical USA, Inc.. (Brauerman, Stephen) Modified on 5/7/2020 (nms). (Entered: 05/06/2020)
5/5/2020
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 117 MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III and Attorney Timothy H. Kratz, filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. Signed by Judge Richard G. Andrews on 5/5/2020. (nms) (Entered: 05/05/2020)
5/5/2020
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III and Attorney Timothy H. Kratz - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Dorsney, Kenneth) (Entered: 05/05/2020)
4/28/2020Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Nanomi B.V. for Lupin Ltd., Lupin Pharmaceuticals Inc. filed by Lupin Ltd., Lupin Pharmaceuticals Inc.. (Murphy, Francis) (Entered: 04/28/2020)
4/22/2020NOTICE OF SERVICE of Defendants Proposed Claim Constructions filed by Lek Pharmaceuticals D.D., Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 04/22/2020)
4/22/2020NOTICE OF SERVICE of Plaintiffs' List of Proposed Claim Constructions filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 04/22/2020)
4/14/2020NOTICE OF SERVICE of Defendants Invagen Pharmaceuticals, Inc. and Cipla USA, Inc.'s Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-9); and Defendants Invagen Pharmaceuticals, Inc. and Cipla USA, Inc.'s Objections and Responses to Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-36) filed by Cipla USA Inc., InvaGen Pharmaceuticals Inc..(O'Byrne, Stephanie) (Entered: 04/14/2020)
4/13/2020NOTICE OF SERVICE of (1) Defendant Teva Pharmaceuticals USA, Inc.'s Response to Plaintiffs' First Set of Interrogatories (NOS. 1-9), (2) Defendant Teva Pharmaceuticals USA, Inc.'s Objections and Responses to Plaintiffs' First Set of Requests for Production (Nos. 1-36), (3) Defendants Sandoz, Inc. and LEK Pharmaceuticals D.D.'s Objections and Responses to Plaintiffs' First Set of Requests for Production (Nos. 1-36), (4) Defendant Sandoz Inc. and LEK Pharmaceuticals D.D.'s Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-9) and (5) this Notice of Service filed by Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 04/13/2020)
4/13/2020NOTICE OF SERVICE of Lupin Ltd. And Lupin Pharmaceuticals, Inc.s Objections and Responses To Plaintiffs First Set Of Interrogatories (NOS. 1-9), and Lupin Ltd. and Lupin Pharmaceuticals, Inc.s Objections And Responses To Plaintiffs First Set Of Requests For Production Of Documents And Things (NOS. 1-36) filed by Lupin Ltd., Lupin Pharmaceuticals Inc..(Murphy, Francis) (Entered: 04/13/2020)
4/13/2020NOTICE OF SERVICE of (1) Apotex's Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-9); and (2) Apotex's Objections and Responses to Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-36) filed by Apotex Corp., Apotex Inc..(Haney, Megan) (Entered: 04/13/2020)
4/13/2020NOTICE OF SERVICE of (1) Defendants' Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-9) to Macleods Pharmaceuticals Ltd. and Macleods Pharma USA Inc.; and (2) Defendants' Objections and Responses to Plaintiffs' First Set of Request for Production of Documents and Things (Nos. 1-36) to Macleods Pharmaceuticals Ltd. and Macleods Pharma USA Inc. filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Haney, Megan) (Entered: 04/13/2020)
4/13/2020NOTICE OF SERVICE of 1) Defendants Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC, and Amneal Pharmaceuticals Company GmbH's Responses to Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-36); and 2) Defendants Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC, and Amneal Pharmaceuticals Company GmbH's Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-9) filed by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Vrana, Robert) (Entered: 04/13/2020)
4/13/2020NOTICE OF SERVICE of Response to Plaintiffs First Set of Interrogatories (Nos. 1-9) and Response to Plaintiffs First Set of Requests for Production of Documents and Things (Nos. 1-36) filed by Shilpa Medicare Limited.(Ormerod, Eve) (Entered: 04/13/2020)
4/13/2020NOTICE OF SERVICE of (1) responses to first set of interrogatories and (2) responses to first set of request for prodution filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Dorsney, Kenneth) (Entered: 04/13/2020)
4/1/2020NOTICE OF SERVICE of Defendants' Joint Claim Terms for Construction (filed on behalf of all defendants) filed by Cipla USA Inc., InvaGen Pharmaceuticals Inc..(O'Byrne, Stephanie) (Entered: 04/01/2020)
4/1/2020NOTICE OF SERVICE of Plaintiffs' List of Proposed Claim Terms for Construction filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) (Entered: 04/01/2020)
3/26/2020Joint STATUS REPORT by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) (Entered: 03/26/2020)
3/2/2020NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Second Set of Common Requests for the Production of Documents and Things filed by Genentech, Inc., InterMune, Inc..(Lyons, Jeffrey) (Entered: 03/02/2020)
2/27/2020NOTICE OF SERVICE of Plaintiffs' First Sets of Interrogatories and First Sets of Requests for Production of Documents and Things to Defendants (directed to various defendants as outlined in notice) filed by Genentech, Inc., InterMune, Inc..(Jacobs, Karen) (Entered: 02/27/2020)
2/21/2020NOTICE OF SERVICE of Defendants' Joint Preliminary Invalidity Contentions (filed on behalf of all defendants) filed by Cipla USA Inc., InvaGen Pharmaceuticals Inc..(O'Byrne, Stephanie) (Entered: 02/21/2020)
2/14/2020 NOTICE of Withdrawal of Counsel Stephen J. Kraftschik, by Genentech, Inc., InterMune, Inc. (Kraftschik, Stephen) Modified on 2/14/2020 (nms). (Entered: 02/14/2020)
2/4/2020NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' First Set of Common Interrogatories to Plaintiffs (Nos. 1-12) and (2) Plaintiffs' Objections and Responses to Defendants' First Set of Common Requests for the Production of Documents and Things filed by Genentech, Inc., InterMune, Inc..(Kraftschik, Stephen) (Entered: 02/04/2020)
1/31/2020NOTICE OF SERVICE of Defendants' Second Set of Common Requests for the Production of Documents and Things filed by Lek Pharmaceuticals d.d., Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 01/31/2020)
1/28/2020NOTICE requesting Clerk to remove Andy J. Miller as co-counsel. Reason for request: No longer at the firm. (Murphy, Francis) (Entered: 01/28/2020)
1/2/2020
  • OrderGranted
SO ORDERED Granting 91 Consent Order of Dismissal in C.A. Nos. 19-78-RGA and 19-104-RGA (*Party Laurus Labs Ltd., Laurus Labs Ltd., Laurus Generics Inc. and Laurus Generics Inc. terminated). Signed by Judge Richard G. Andrews on 1/2/2020. (nms) (Entered: 01/02/2020)
1/2/2020
  • Order
SO ORDERED re 90 Consent Order of Dismissal in C.A. No. 19-177-RGA (*Party Alembic Pharmaceuticals Ltd., Alembic Global Holding SA and Alembic Pharmaceuticals Inc. terminated). Signed by Judge Richard G. Andrews on 1/2/2020. (nms) (Entered: 01/02/2020)
1/2/2020
  • Order
SO ORDERED re 89 Consent Order of Dismissal in C.A. No. 19-205-RGA (*Party MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. terminated). Signed by Judge Richard G. Andrews on 1/2/2020. (nms) (Entered: 01/02/2020)
1/2/2020
  • Motion to Dismiss (Demurrer)
SO ORDERED re 87 Stipulation of Dismissal (*Party Aizant Drug Research Solutions Pvt. Ltd. terminated). Signed by Judge Richard G. Andrews on 12/20/2019. (nms) (Entered: 01/02/2020)
12/27/2019
  • Motion to Dismiss (Demurrer)
STIPULATION of Dismissal as to Laurus Labs Ltd. and Laurus Generics Inc., by Genentech, Inc., InterMune, Inc.. (Kraftschik, Stephen) Modified on 1/2/2020 (nms). (Entered: 12/27/2019)
12/26/2019
  • Motion to Dismiss (Demurrer)
STIPULATION of Dismissal as to Alembic Defendants,by Genentech, Inc., InterMune, Inc.. (Kraftschik, Stephen) Modified on 12/27/2019 (nms). (Entered: 12/26/2019)
12/26/2019
  • Motion to Dismiss (Demurrer)
STIPULATION of Dismissal of MSN Defendants, by Genentech, Inc., InterMune, Inc.. (Kraftschik, Stephen) Modified on 12/27/2019 (nms). (Entered: 12/26/2019)
12/20/2019NOTICE OF SERVICE of Defendants' First Set of Common Interrogatories to Plaintiffs (Nos. 1-12) and Defendants' First Set of Common Requests for the Production of Documents and Things filed by Alembic Global Holding SA, Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd., Lek Pharmaceuticals d.d., Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 12/20/2019)
12/20/2019
  • Motion to Dismiss (Demurrer)
STIPULATION of Dismissal as to Aizant Drug Research Solutions Pvt. Ltd., by Genentech, Inc., InterMune, Inc.. (Kraftschik, Stephen) Modified on 12/20/2019 (nms). (Entered: 12/20/2019)
12/20/2019
  • OrderGranted
SO ORDERED Granting 85 Consent Order of Dismissal in C.A. Nos. 19-141-RGA and 19-142-RGA. Signed by Judge Richard G. Andrews on 12/20/2019. (nms) (Entered: 12/20/2019)
12/19/2019PROPOSED Consent Order of Dismissal in C.A. Nos. 19-141-RGA and 19-142-RGA, by Genentech, Inc., InterMune, Inc.. (Kraftschik, Stephen) Modified on 12/20/2019 (nms). (Entered: 12/19/2019)
12/19/2019NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts filed by Genentech, Inc., InterMune, Inc..(Kraftschik, Stephen) (Entered: 12/19/2019)
12/17/2019 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/14/2019. Date of Expiration of Patent: multiple expiration dates from 9/22/2026 through 8/30/2033.Thirty Month Stay Deadline: 5/14/2022. (Kraftschik, Stephen) (Entered: 12/17/2019)
12/17/2019Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/9/2019. Date of Expiration of Patent: multiple expiration dates from 9/22/2026 through August 30, 2033.Thirty Month Stay Deadline: 6/9/2022. (Kraftschik, Stephen) (Entered: 12/17/2019)
12/17/2019Amended Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,566,729 B1; 7,635,707 B1 ;7,767,700 B2; 7,816,383 B1 ;7,910,610 B1; 8,013,002 B2 ;8,084,475 B2; 8,318,780 B2 ;8,420,674 B2; 8,592,462 B2 ;8,609,701 B2; 8,648,098 B2 ;8,754,109 B2. (Kraftschik, Stephen) Modified on 12/17/2019 (nms). (Entered: 12/17/2019)
12/16/2019
  • Complaint
FIRST AMENDED COMPLAINT for Patent Infringement against Aizant Drug Research Solutions Pvt. Ltd.- filed by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibits 1-15)(nms) (Entered: 12/16/2019)
12/16/2019
  • Motion to File Amended ComplaintGranted
SO ORDERED, re 78 Stipulation and Proposed Order Granting Leave to File First Amended Complaint for Patent Infringement against Aizant Drug Research Solutions Pvt. Ltd.. Signed by Judge Richard G. Andrews on 12/16/2019. (nms) (Entered: 12/16/2019)
12/16/2019
  • Complaint
FIRST AMENDED COMPLAINT for Patent Infringement against MSN Laboratories Private Limited, and MSN Pharmaceuticals Inc.- filed by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Exhibits 1-15)(nms) (Entered: 12/16/2019)
12/16/2019
  • Motion to File Amended ComplaintGranted
SO ORDERED, re 77 Stipulation and Proposed Order Granting Leave to File First Amended Complaint for Patent Infringement against MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 12/16/2019. (nms) (Entered: 12/16/2019)
12/13/2019
  • Motion to File Amended Complaint
STIPULATION for Leave to File Amended Complaint Against Aizant by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Amended Complaint, # 2 Exhibits 1-15 to Amended Complaint)(Kraftschik, Stephen) (Entered: 12/13/2019)
12/13/2019
  • Motion to File Amended Complaint
STIPULATION for Leave to File Amended Complaint, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Amended Complaint, # 2 Exhibits 1-15)(Kraftschik, Stephen) Modified on 12/13/2019 (nms). (Entered: 12/13/2019)
12/10/2019NOTICE requesting Clerk to remove Joseph Schramm, III as co-counsel. Reason for request: No longer working on the case. (Haney, Megan) (Entered: 12/10/2019)
11/25/2019NOTICE of Appearance by Stephanie E. O'Byrne on behalf of Cipla USA Inc., InvaGen Pharmaceuticals Inc. (O'Byrne, Stephanie) (Entered: 11/25/2019)
11/25/2019NOTICE of Appearance by Tracey E. Timlin on behalf of Cipla USA Inc., InvaGen Pharmaceuticals Inc. (Timlin, Tracey) (Entered: 11/25/2019)
11/12/2019
  • Motion for Protective Order
PROTECTIVE ORDER. Signed by Judge Richard G. Andrews on 11/12/2019. (nms) (Entered: 11/12/2019)
11/8/2019Letter to The Honorable Richard G. Andrews, from Jack B. Blumenfeld, regarding protective order dispute. (Attachments: # 1 Exhibits 1-12)(Blumenfeld, Jack) Modified on 11/8/2019 (nms). (Entered: 11/08/2019)
11/8/2019Letter to The Honorable Richard G. Andrews, from Stephen B. Brauerman, regarding protective order dispute. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Brauerman, Stephen) Modified on 11/8/2019 (nms). (Entered: 11/08/2019)
11/7/2019Letter to The Honorable Richard G. Andrews, dated 11/7/2019, from Stephen J. Kraftschick, enclosing the proposed protective order, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Proposed Order)(Kraftschik, Stephen) Modified on 11/7/2019 (nms). Modified on 11/7/2019 (nms). (Entered: 11/07/2019)
10/28/2019NOTICE OF SERVICE of LUPIN Ltd. and LUPIN PHARMACEUTICALS, Inc.s Product Samples pursuant to Paragraph 3.b of the Scheduling Order filed by Lupin Ltd., Lupin Pharmaceuticals Inc..(Murphy, Francis) (Entered: 10/28/2019)
10/28/2019CONSENT ORDER of Dismissal in C.A. No. 19-111(RGA) (*Party Micro Labs Ltd. and Micro Labs USA Inc. terminated). Signed by Judge Richard G. Andrews on 10/25/2019. (nms) (Entered: 10/28/2019)
10/24/2019NOTICE OF SERVICE of Laurus' Product Samples pursuant to Paragraph 3.b of the Scheduling Order filed by Laurus Generics Inc., Laurus Labs Ltd..(Orlacchio, Adam) (Entered: 10/24/2019)
10/24/2019STIPULATION Consent Order of Dismissal, by Genentech, Inc., InterMune, Inc.. (Kraftschik, Stephen) Modified on 10/24/2019 (nms). (Entered: 10/24/2019)
10/16/2019SO ORDERED, re 65 STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to October 29, 2019. Signed by Judge Richard G. Andrews on 10/15/2019. (nms) (Entered: 10/16/2019)
10/15/2019 STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to October 29, 2019 - filed by Genentech, Inc., InterMune, Inc.. (Kraftschik, Stephen) (Entered: 10/15/2019)
10/8/2019NOTICE OF SERVICE of Core Technical Documents Pursuant to Paragraph 3(a) of the Case Scheduling Order filed by Alembic Global Holding SA, Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd., Lek Pharmaceuticals d.d., Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 10/08/2019)
10/8/2019SO ORDERED, re 52 STIPULATION TO EXTEND TIME for Parties to Submit a Protective Order to October 15, 2019. Signed by Judge Richard G. Andrews on 10/8/2019. (nms) (Entered: 10/08/2019)
10/8/2019NOTICE OF SERVICE of Defendants InvaGen Pharmaceuticals, Inc. and Cipla USA, Inc.'s Production of Core Technical Documents [Confidential-Attorney's Eyes Only] filed by Cipla USA Inc., InvaGen Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 10/08/2019)
10/8/2019NOTICE OF SERVICE of Defendant Shilpa Medicare Limited's Core Technical Documents Pursuant to Paragraph 4(b) of the Default Standard for Discovery filed by Shilpa Medicare Limited.(Ormerod, Eve) (Entered: 10/08/2019)
10/8/2019NOTICE OF SERVICE of Core Technical Documents, filed by Lupin Ltd., Lupin Pharmaceuticals Inc..(Murphy, Francis) Modified on 10/9/2019 (nms). (Entered: 10/08/2019)
10/8/2019NOTICE OF SERVICE of Core Technical Documents, filed by Lupin Ltd., Lupin Pharmaceuticals Inc..(Murphy, Francis) Modified on 10/9/2019 (nms). (Entered: 10/08/2019)
10/8/2019NOTICE OF SERVICE of Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.'s Production of Core Technical Documents filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Haney, Megan) (Entered: 10/08/2019)
10/8/2019NOTICE OF SERVICE of 1) Amneal's Core Technical Documents; and 2) Amneal's Samples of the Accused Products filed by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Vrana, Robert) (Entered: 10/08/2019)
10/8/2019NOTICE OF SERVICE of Apotex's Production of Core Technical Documents filed by Apotex Corp., Apotex Inc..(Haney, Megan) (Entered: 10/08/2019)
10/7/2019NOTICE OF SERVICE of Production of Core Technical Documents filed by Aizant Drug Research Solutions Pvt. Ltd..(Stamoulis, Stamatios) (Entered: 10/07/2019)
10/7/2019NOTICE OF SERVICE of Production of Core Technical Documents filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 10/07/2019)
10/7/2019NOTICE OF SERVICE of Core Technical Documents filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Dorsney, Kenneth) (Entered: 10/07/2019)
10/7/2019NOTICE OF SERVICE of Laurus' production pursuant to Paragraph 3.b of the Scheduling Order filed by Laurus Generics Inc., Laurus Labs Ltd..(Orlacchio, Adam) (Entered: 10/07/2019)
10/7/2019 STIPULATION TO EXTEND TIME for Parties to Submit a Protective Order to October 15, 2019 - filed by Alembic Global Holding SA, Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd., Sandoz Inc., Teva Pharmaceutical USA, Inc.. (Brauerman, Stephen) (Entered: 10/07/2019)
10/7/2019NOTICE OF SERVICE of InvaGen and Cipla Defendants' Paragraph 3 Disclosures Regarding Discovery filed by Cipla USA Inc., InvaGen Pharmaceuticals Inc..(O'Byrne, Stephanie) (Entered: 10/07/2019)
10/7/2019NOTICE OF SERVICE of InvaGen Defendants' Initial Disclosures filed by Cipla USA Inc., InvaGen Pharmaceuticals Inc..(O'Byrne, Stephanie) (Entered: 10/07/2019)
10/7/2019NOTICE OF SERVICE of Core Technical Documents filed by Micro Labs Ltd., Micro Labs USA Inc..(Dorsney, Kenneth) (Entered: 10/07/2019)
10/1/2019SO ORDERED, re 48 STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to October 7, 2019. Signed by Judge Richard G. Andrews on 10/1/2019. (nms) (Entered: 10/01/2019)
9/30/2019 STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to October 7, 2019 - filed by Genentech, Inc., InterMune, Inc.. (Kraftschik, Stephen) (Entered: 09/30/2019)
9/23/2019Pro Hac Vice Attorneys Cindy Chang and Kevin J. DeJong for Alembic Global Holding SA, Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd., Lek Pharmaceuticals d.d., Sandoz Inc., and Teva Pharmaceutical USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (amf) (Entered: 09/23/2019)
9/20/2019NOTICE OF SERVICE of Defendant Accord Healthcare, Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Accord Healthcare Inc..(Schladweiler, Benjamin) (Entered: 09/20/2019)
9/20/2019NOTICE OF SERVICE of Defendant Accord Healthcare, Inc.'s Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Accord Healthcare Inc..(Schladweiler, Benjamin) (Entered: 09/20/2019)
9/20/2019Pro Hac Vice Attorney Dan Liu for Genentech, Inc., for InterMune, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) (Entered: 09/20/2019)
9/20/2019Pro Hac Vice Attorney Kathleen Gersh for Genentech, Inc., for InterMune, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) (Entered: 09/20/2019)
9/20/2019Pro Hac Vice Attorney Alexandra Cavazos for Genentech, Inc., for InterMune, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) (Entered: 09/20/2019)
9/20/2019NOTICE OF SERVICE of Sandoz, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) (19-202), LEK Pharmaceuticals D.D.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) (19-202), Sandoz, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) (19-203), LEK Pharmaceuticals D.D.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) (19-203), Teva Pharmaceuticals USA, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) (19-136), Alembic Pharmaceuticals, LTD., Alembic Global Holdings SA, and Alembic Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26 (a)(1) (19-177), Teva Pharmaceuticals USA, Inc.'s Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery (19-136), Alembic Pharmaceuticals, LTD., Alembic Global Holdings SA, and Alembic Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery (19-177), LEK Pharmaceuticals D.D.'s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery (19-202), LEK Pharmaceuticals D.D.'s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery (19-203), Sandoz, Inc.'s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery (19-202), Sandoz, Inc.'s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery (19-203), Sandoz, Inc.'s Corrected Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) (19-202), and LEK Pharmaceuticals D.D.'s Corrected Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) (19-202) filed by Alembic Global Holding SA, Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd., Lek Pharmaceuticals d.d., Sandoz Inc., Teva Pharmaceutical USA, Inc..(Brauerman, Stephen) (Entered: 09/20/2019)
9/20/2019 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG, Corporate Parent Novartis Pharma AG for Lek Pharmaceuticals d.d. filed by Lek Pharmaceuticals d.d.. (Brauerman, Stephen) (Entered: 09/20/2019)
9/20/2019
  • Answer
Answer to First Amended Complaint, Affirmative Defenses and Counterclaims (see C.A. No. 19-203-RGA), by Lek Pharmaceuticals d.d.. (Brauerman, Stephen) Modified on 9/20/2019 (nms). (Entered: 09/20/2019)
9/20/2019
  • Answer
Answer to First Amended Complaint, Affirmative Defenses and Counterclaims (see C.A. No. 19-202-RGA) by Lek Pharmaceuticals d.d.. (Brauerman, Stephen) Modified on 9/20/2019 (nms). (Entered: 09/20/2019)
9/20/2019
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 41 MOTION for Pro Hac Vice Appearance of Attorney Kathleen Gersh, Alexandra Cavazos and Dan Liu, filed by Genentech, Inc., InterMune, Inc.. Signed by Judge Richard G. Andrews on 9/20/2019. (nms) (Entered: 09/20/2019)
9/20/2019
  • Motion to Appear Pro Hac Vice
MOTION for Pro Hac Vice Appearance of Attorney Kathleen Gersh, Alexandra Cavazos and Dan Liu - filed by Genentech, Inc., InterMune, Inc.. (Kraftschik, Stephen) (Entered: 09/20/2019)
9/19/2019NOTICE OF SERVICE of Defendants' Disclosures Pursuant to Paragraph 3 of the District of Delaware's Default Standard for Discovery including Discovery of Electronically Stored Information (ESI) filed by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Vrana, Robert) (Entered: 09/19/2019)
9/19/2019NOTICE OF SERVICE of Shilpa Medicare Limited's Delaware Default Standard Paragraph 3 Disclosures filed by Shilpa Medicare Limited.(Belgam, Neal) (Entered: 09/19/2019)
9/19/2019NOTICE OF SERVICE of Apotex's Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Apotex Corp., Apotex Inc..(Haney, Megan) (Entered: 09/19/2019)
9/19/2019NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Genentech, Inc., InterMune, Inc..(Kraftschik, Stephen) (Entered: 09/19/2019)
9/19/2019NOTICE OF SERVICE of Initial Disclosures Pursuant to Paragraph 3 of the Court's Default Standard for Discovery on Behalf of Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc. filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Haney, Megan) (Entered: 09/19/2019)
9/19/2019NOTICE OF SERVICE of Rule 26(a)(1) Initial Disclosures filed by Lupin Ltd., Lupin Pharmaceuticals Inc..(Murphy, Francis) (Entered: 09/19/2019)
9/19/2019NOTICE OF SERVICE of Rule 26(a)(1) Initial Disclosures filed by Lupin Ltd., Lupin Pharmaceuticals Inc..(Murphy, Francis) (Entered: 09/19/2019)
9/19/2019NOTICE OF SERVICE of Paragraph 3 Disclosures filed by Lupin Ltd., Lupin Pharmaceuticals Inc..(Parshall, Jonathan) (Entered: 09/19/2019)
9/19/2019NOTICE OF SERVICE of Paragraph 3 Disclosures filed by Lupin Ltd., Lupin Pharmaceuticals Inc..(Parshall, Jonathan) (Entered: 09/19/2019)
9/19/2019NOTICE OF SERVICE of Laurus' Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Laurus Generics Inc., Laurus Labs Ltd..(Orlacchio, Adam) (Entered: 09/19/2019)
9/19/2019NOTICE OF SERVICE of Micro Labs' Paragraph 3 Disclosures filed by Micro Labs Ltd., Micro Labs USA Inc..(Dorsney, Kenneth) (Entered: 09/19/2019)
9/19/2019NOTICE OF SERVICE of Aurobindo's Paragraph 3 Disclosures filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Dorsney, Kenneth) (Entered: 09/19/2019)
9/6/2019Official Transcript of Scheduling Conference held on 08/20/19 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Telephone number 302-573-6195. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 9/27/2019. Redacted Transcript Deadline set for 10/7/2019. Release of Transcript Restriction set for 12/5/2019. (Triozzi, Heather) (Entered: 09/06/2019)
9/5/2019NOTICE OF SERVICE of Laurus Labs Ltd. and Laurus Generics Inc.'s Supplemental Rule 26 Initial Disclosures filed by Laurus Generics Inc., Laurus Labs Ltd..(Orlacchio, Adam) (Entered: 09/05/2019)
9/5/2019NOTICE OF SERVICE of Defendant's Rule 26(a)(1) Initial Disclosures filed by Amneal Pharmaceuticals LLC.(Vrana, Robert) (Entered: 09/05/2019)
9/5/2019NOTICE OF SERVICE of Apotex Inc. and Apotex Corp.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Apotex Corp., Apotex Inc..(Haney, Megan) (Entered: 09/05/2019)
9/5/2019NOTICE OF SERVICE of Shilpa Medicare Limited's Initial Disclosures Pursuant to Rule 26(a)(1) filed by Shilpa Medicare Limited.(Ormerod, Eve) (Entered: 09/05/2019)
9/5/2019NOTICE OF SERVICE of Initial Disclosures of Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc. filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Haney, Megan) (Entered: 09/05/2019)
9/5/2019NOTICE OF SERVICE of Micro Labs' Rule 26(a)(1) Initial Disclosures filed by Micro Labs Ltd., Micro Labs USA Inc..(Dorsney, Kenneth) (Entered: 09/05/2019)
9/5/2019NOTICE OF SERVICE of Aurobindo's Rule 26(a)(1) Initial Disclosures filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Dorsney, Kenneth) (Entered: 09/05/2019)
9/5/2019NOTICE OF SERVICE of (1) Plaintiffs' Rule 26(a)(1) Disclosures and (2) Plaintiffs' Paragraph 4(a) Disclosures as to all related cases filed by Genentech, Inc., InterMune, Inc..(Kraftschik, Stephen) (Entered: 09/05/2019)
9/3/2019CASE REFERRED to Magistrate Judge Sherry R. Fallon for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:19-cv-00078-RGA et al.(cak) (Entered: 09/03/2019)
9/3/2019
  • Scheduling Order
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 11/12/2020. Joint Claim Construction Brief due by 8/26/2020. A Markman Hearing is set for 9/23/2020, at 8:30 AM in Courtroom 6A. A Pretrial Conference is set for 10/22/2021, at 8:30 AM in Courtroom 6A. A Bench Trial is set for 11/8/2021, at 9:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 8/30/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms) (Entered: 09/03/2019)
8/30/2019PROPOSED Scheduling Order, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Letter)(Jacobs, Karen) Modified on 8/30/2019 (nms). (Entered: 08/30/2019)
8/20/2019Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 8/20/2019. Local counsel present for plaintiffs: J. Blumenfeld. Local counsel present for defendants: S. Brauerman, A. Orlacchio, S. O'Byrne, S. Stamoulis, A. Gaza, E. Ormerod, B. Schladweiler, J. Parshall, M. Haney, K. Dorsney. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-cv-00078-RGA et al.(crb) (Entered: 08/20/2019)
8/16/2019 PROPOSED Scheduling Order, by Genentech, Inc., InterMune, Inc.. (Attachments: # 1 Letter)(Jacobs, Karen) Modified on 8/20/2019 (nms). (Entered: 08/16/2019)
5/16/201916
  • Order
ORAL ORDER SETTING RULE 16(b) CONFERENCE: A scheduling conference pursuant to Fed. R. Civ. P. 16(b) will be held on Tuesday, August 20, 2019, at 2:30 p.m., in Courtroom 6A of the Boggs Federal Building, 844 King Street, Wilmington, Delaware. Plaintiffs counsel shall coordinate a dial in number for all parties wishing to participate, but not physically being able to do so. The dial in number will be for listening capacity only. Parties shall confer about scheduling and discovery limitations, and attempt to reach agreement. The parties shall use as a basis for discussion the Courts Rule 16 Scheduling Order patent, available on the Courts website. No later than 48 hours before the scheduling conference, the parties shall file a proposed scheduling order using the Rule 16 Scheduling Order - patent. The parties shall direct any requests or questions regarding the scheduling or management of this case to the Courts Case Manager at (302) 573-6137. Ordered by Judge Richard G. Andrews on 5/16/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms) (Entered: 05/16/2019)
3/28/2019
  • Answer
ANSWER to 12 Answer to Complaint, and Counterclaims, by Genentech, Inc., InterMune, Inc..(Jacobs, Karen) Modified on 3/29/2019 (nms). (Entered: 03/28/2019)
3/8/2019Pro Hac Vice Attorneys Ryan Hagglund, Warren K. MacRae, and Mark E. Waddell for Genentech, Inc. and InterMune, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00078-RGA et al.(ddp) (Entered: 03/08/2019)
3/7/2019NOTICE OF SERVICE of Defendants' Initial Disclosures filed by Laurus Generics Inc., Laurus Labs Ltd..(Orlacchio, Adam) (Entered: 03/07/2019)
3/7/2019 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Laurus Generics Inc., Laurus Labs Ltd.. (Orlacchio, Adam) (Entered: 03/07/2019)
3/7/2019
  • Answer
ANSWER to 1 Complaint, and COUNTERCLAIMS against Genentech, Inc., InterMune, Inc. by Laurus Generics Inc., Laurus Labs Ltd..(Orlacchio, Adam) Modified on 3/7/2019 (nms). (Entered: 03/07/2019)
2/12/2019
  • Order
SO ORDERED, re (11 in 19-cv-78-RGA, 8 in 19-cv-154-RGA, 7 in 19-cv-202-RGA, 8 in 19-cv-130-RGA, 9 in 19-cv-103-RGA, 9 in 19-cv-110-RGA, 9 in 19-cv-123-RGA, 8 in 19-cv-205-RGA, 8 in 19-cv-219-RGA, 10 in 19-cv-178-RGA, 13 in 19-cv-131-RGA, 7 in 19-cv-223-RGA, 7 in 19-cv-142-RGA, 7 in 19-cv-136-RGA, 11 in 19-cv-104-RGA, 8 in 19-cv-190-RGA, 7 in 19-cv-141-RGA, 8 in 19-cv-177-RGA, 13 in 19-cv-132-RGA, 9 in 1:19-cv-00120-RGA, 8 in 19-cv-111-RGA, 8 in 19-cv-195-RGA, 9 in 19-cv-105-RGA, 9 in 1:19-cv-00109-RGA, 7 in 19-cv-203-RGA, 10 in 19-cv-164-RGA) MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP filed by Genentech, Inc., InterMune, Inc.. Signed by Judge Richard G. Andrews on 2/12/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms) (Entered: 02/12/2019)
2/11/2019
  • Motion to Appear Pro Hac Viceby Π
MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP - filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) (Entered: 02/11/2019)
1/31/2019Pro Hac Vice Attorneys Christopher K. Hu, Brian Higgins, and Jonathan W.S. England for Laurus Generics Inc. and Laurus Labs Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp) (Entered: 01/31/2019)
1/31/2019
  • Order
SO ORDERED, re (10 in 19-cv-78-RGA, 10 in 19-cv-104-RGA) MOTION for Pro Hac Vice Appearance of Attorney Brian Wm. Higgins, Christopher K. Hu, and Jonathan W.S. England, filed by Laurus Labs Ltd., Laurus Generics Inc.. Signed by Judge Richard G. Andrews on 1/31/2019. Associated Cases: 1:19-cv-00078-RGA, 1:19-cv-00104-RGA(nms) (Entered: 01/31/2019)
1/30/2019
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Brian Wm. Higgins, Christopher K. Hu, and Jonathan W.S. England - filed by Laurus Generics Inc., Laurus Labs Ltd.. (Orlacchio, Adam) (Entered: 01/30/2019)
1/29/2019
  • Motion to Extend Time
SO ORDERED, re 9 Stipulation and Order to Extend Time to Answer, Move or Otherwise Respond to the Complaint (*Reset Answer Deadlines: Laurus Generics Inc. answer due 3/7/2019; Laurus Labs Ltd. answer due 3/7/2019). Signed by Judge Richard G. Andrews on 1/29/2019. (nms) (Entered: 01/29/2019)
1/29/2019
  • Motion to Extend Time
STIPULATION and [Proposed] Order to Extend Time for Defendants to Answer, Move or Otherwise Respond to the Complaint, by Laurus Generics Inc., Laurus Labs Ltd.. (Orlacchio, Adam) Modified on 1/29/2019 (nms). (Entered: 01/29/2019)
1/28/2019NOTICE of Appearance by Adam V. Orlacchio on behalf of Laurus Generics Inc., Laurus Labs Ltd. (Orlacchio, Adam) (Entered: 01/28/2019)
1/17/2019CORRECTING ENTRY: The pdf for D.I. 4 has been replaced with a corrected version per counsel's request. The issue dates for patents has been amended. (nms) (Entered: 01/17/2019)
1/16/2019AFFIDAVIT of Service for Complaint served on Laurus Labs Ltd. on January 16, 2019, filed by Genentech, Inc., InterMune, Inc.. (Blumenfeld, Jack) (Entered: 01/16/2019)
1/16/2019Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) (Entered: 01/16/2019)
1/15/2019Return of Service Executed by InterMune, Inc., Genentech, Inc.. Laurus Generics Inc. served on 1/15/2019, answer due 2/5/2019. (Blumenfeld, Jack) (Entered: 01/15/2019)
1/15/2019Summons Issued with Magistrate Consent Notice attached as to Laurus Generics Inc. on 1/15/2019; Laurus Labs Ltd. on 1/15/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) (Entered: 01/15/2019)
1/14/2019 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Genentech, Inc. for InterMune, Inc.; Other Affiliate Roche Holding Ltd., Other Affiliate Novartis Ltd., Other Affiliate Roche Holdings, Inc. for Genentech, Inc. filed by Genentech, Inc., InterMune, Inc.. (nmg) (Entered: 01/15/2019)
1/14/2019Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,767,225 B2; 7,988,994 B2; 8,383,150 B2; 8,753,679 B2; 7,696,236 B2; 7,767,700 B2; 8,420,674 B2; 7,566,729 B1; 7,635,707 B1; 8,592,462 B2; 8,609,701 B2; 7,816,383 B1; 7,910,610 B1; 8,013,002 B2; 8,084,475 B2; 8,318,780 B2; 8,648,098 B2; 8,754,109 B2; 8,778,947 B2. (nmg) (Main Document 4 replaced on 1/17/2019) (nms). (Entered: 01/15/2019)
1/14/2019 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/3/2018. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 4/15/2022. (nmg) (Entered: 01/15/2019)
1/14/2019Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) (Entered: 01/15/2019)
1/14/2019
  • Complaint
COMPLAINT for PATENT INFRINGEMENT filed against Laurus Generics Inc. and Laurus Labs Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2543903.) - filed by InterMune, Inc., Genentech, Inc.. (Attachments: # 1 Exhibit 1-19, # 2 Civil Cover Sheet)(nmg) (Entered: 01/15/2019)